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dialogue

		The changing
world of mental health
the science behind mental health has long been one of Yale’s
strengths. Robert J. Alpern, MD, dean and Ensign Professor of
Medicine, talks about the direction of the field today and why society
ought to do a better job of taking mental health issues seriously.
What are the key challenges facing people who need mental health treatment?

Mental health care has changed significantly since I entered medicine. Patients
with significant mental health disorders were hospitalized for lengthy stays and
the public probably envisioned those stays as being something like that described
by Ken Kesey in the 1962 novel One Flew Over the Cuckoo’s Nest. Now, most are
treated as outpatients and there’s more emphasis on medication, with less emphasis on psychotherapy.
What changed? In the past, mental health was viewed as a problem on the periphery
of medicine that most physicians could not fully comprehend and wanted to avoid.
An understanding of the neuroscience wasn’t really there for drug development, nor
was the technology sophisticated enough to image or treat chemical imbalances or
physical trauma. We now realize that mental health is central to overall wellness.
Mental health is a major concern for this country and the world. We don’t treat it well
at all and I think we’re all aware of that now. We need to make meaningful changes.
Is there anything we can do to fix the system? The entire system is underfunded,
to begin with, but the cost that it would take to really treat mental health disorders
as they should be treated would be very large. Still, the costs to society of not
treating these conditions have been and will continue to be enormous. The question
of how serious we want to be about treating mental health is one of the great
challenges we face as a country.
Does technology hold any hope for improved accessibility or treatment? The short
answer is yes. The longer answer is that technology is always advancing, and
the tools we’ve needed to diagnose underlying biological or chemical causes of
mental health disorders are still being developed. Here at Yale we have an outstanding neuroscience program, an outstanding psychiatry department, and an
outstanding neuroscience imaging program. I’m confident that our researchers
will be playing a major role in making quality psychiatric care more available.
Will mental health be a right some day? It’s hard to say that mental health is or will be a

right. But I think it’s a right to have access to the best mental health treatment. We need
to significantly improve our treatments and patient access to those treatments.
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			New stem-cell
cultivation procedure
		 boosts hope for cures
when the taylor lab in Yale’s Division of Reproductive
Sciences extracted stem cells from human endometrial
tissue—more commonly known as the uterine lining—
the researchers were proud of their accomplishment.
They didn’t think the find was extraordinary, and they
certainly didn’t imagine that it might lead to treatments
for a neurodegenerative condition. They were wrong—
and happily so.
“The best discoveries throughout the history of science have
not been predictable, have not
always come out the way we
anticipated they would, or the
way we designed them to,” says
Hugh Taylor, MD, HS ’92, FW ’98,
chair and the Anita O’Keeffe
Young Professor of Obstetrics,
Gynecology, and Reproductive
Sciences, and professor of molecular, cellular, and developmental
biology. “That’s the real excitement in science—when it doesn’t
follow the predicted path, when
you get a surprise.”
The surprise, in this case,
wasn’t finding the multipotent stem cells but finding
their proclivity to differentiate
into dopaminergic neurons:
the brain cells whose loss in
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Parkinson’s disease leads to
tremor, speech difficulty, poor
balance, and a host of other
symptoms. A reproductive sciences laboratory like Taylor’s
is not where one would
expect to find a treatment for
Parkinson’s disease.
“There certainly aren’t dopaminergic neurons in the uterus,”
Taylor says.
Though unintended, the
discovery has been serendipitous and is unfolding quickly;
so far, the team has demonstrated the neurons’ ability to
boost fallen dopamine levels

in mouse and primate models
of mild Parkinson’s disease. In
future studies, the team hopes
to examine more severe forms
of the disease to identify the
therapy’s effects on physical
symptoms beyond improving
dopamine levels.
The stem cells’ tendency to
differentiate into dopaminergic
neurons is as yet unexplained, but
Taylor and his colleagues have
also coaxed the cells into becoming insulin-producing beta cells.
Trials in mouse models have used
endometrial stem cells to produce
beta cells that continued producing insulin and stabilized bloodglucose levels within five weeks
when injected into diabetic mice.
Taylor credits the cascading
discoveries not only to his team
and colleagues in other departments but to the collaborative
atmosphere that facilitates the
researchers’ interactions.
“For each of these applications
[of endometrial stem cells],
we found the world’s expert
right in our backyard,” he says.
“You have world-leading experts
in these diseases right down
the hall, or in the building
across the street, who are more
than glad to help advance colleagues’ research as collaborators.” It helps that stem cells are
a valuable currency across all of
medicine because of their unique
ability to produce myriad different cell types—when given the
right environment. The endometrium, regenerating month
by month for years, is just such
an environment.

Hugh Taylor hopes that
the new procedure for
sustainably harvesting
stem cells will lead to
extraordinary new
developments in personalized medicine, and
aid in further medical
research into how
cells differentiate.

R O B E R T L I S A K P H OTO

While adult stem cells reside
in many different tissues, finding and extracting them in great
numbers is challenging and—in
all instances but one—invasive.
The endometrium is the only tissue from which adult stem cells
can be retrieved via a routine
office-based procedure without
anesthetic. This source is not
limited to women of reproductive age, either: estrogen treatment can stimulate endometrial
growth in women of all ages.
Treatments that use a patient’s
own cells are attractive because
they eliminate the risk of tissue
rejection. Taylor envisions tissue
banks that would use material
retrieved from hysterectomies

to obtain additional stem cells.
These could then be used to treat
people without a uterus.
“There are tremendous applications in almost all fields of
medicine. I think the sky’s
the limit, really,” Taylor said.
“Any disease where cells become
defective or die, we can consider using stem cells to replace
them.” Parkinson’s disease
and diabetes are only two of
thousands of medical conditions that could one day be
treated—or cured—with cellbased therapies.
“Stem cell research has shown
potency; it has tremendous
potential,” Taylor said. “I think
that cell-based therapy can do
things that drugs could never
do, and I think we’ll see a lot
more cell-based therapies on
the horizon.”
—Natasha Strydhorst

»

Vectors: An insect variation on viral visitations
Few scientists view the immune
system as a binary between
human and nonhuman infection.
In many cases—dozens known
for certain to science, and likely
thousands or millions given the
variety of life forms in animal
bodies—bacteria and viruses have
evolved along with more complicated organisms, becoming inextricably linked to health. It may
not be accurate to describe these
ancient intruders as separable
from a “healthy” body—although,
strictly speaking, they are undeniably infections.
The human immune system
and its bacterial allies aren’t the
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Surgical residencies
based on the methods
of William Steward Halsted have long been the
gold standard for aspiring surgeons. They’ve
also been very hard on
the physicians who go
through them, and the
idea of single-minded
devotion to craft may
have contributed to
physician burnout and
addiction later on in life.
Current surgical faculty
at YSM are pushing to
change how surgical
residencies function …
for the better.
For more on surgical
residencies, visit ymm.
yale.edu/surgicalres
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researchers,” says Munstermann.
“Sand flies, mosquitos like the
dreaded Asian Tiger Aedes
albopictus, ticks, tsetse flies,
and other arthropods harbor
within them a host of debilitatonly line of defense against hosing diseases that are anathema
tile diseases, though. As sciento human health.”
tists reevaluate what constitutes
A longtime source of illness
immunity on an individual level,
and debilitation for humans, ticks
the health of vectors, the means
are a vector that has rebounded
by which hostile viruses and
as New England farmland has
bacteria are transmitted into
receded and forests have regrown.
human bodies, has taken on a
Sukanya Narasimhan, PhD,
new significance.
FW ’93, a senior research scien“A vector is an organism that
tist in the Section of Infectious
serves as a necessary intermediDiseases, studies the microbiome
ary for human disease, or other
of the deer tick in collaboration
animal diseases,” says Leonard
with Erol Fikrig, MD, FW ’92, the
Munstermann, PhD, a senior
Waldemar von Zedtwitz Professor
research scientist in epidemiolof Medicine (Infectious Diseases),
ogy (microbial diseases) at the
professor of epidemiology (microYale School of Public Health.
bial diseases), of microbial pathoMunstermann focuses on
genesis, and chief of the Section of
population genetics and taxoInfectious Diseases. Together the
nomic relationships among the
two researchers hope to identify
400 species of South American
ways to reduce the tick’s ability
phlebotomine sand flies, some
to host pathogens that are danof which are responsible for
gerous to humans and humanspreading leishmaniasis.
adjacent animals.
Past efforts to control vectors
Narasimhan says that as evihave included wildly destrucdence mounted about the mamtive assaults on the environment.
malian microbiomes and their
Alongside developing medical
impact on human health, “We
technology, ecological awareness
wondered if ticks might harbor
has led to other ways to affect
microbiota, and if their indigvectors. Most recently these
enous bacteria affect the tick,
include attempts to strengthen
how it acquires pathogens, and
their immune systems against
how it passes them on to us.”
infection. Researchers hope to
She adds, “Tick prevalence
preserve animals and microbes
doesn’t necessarily mean infecthat may be crucial to the food
tion prevalence, so there could
chain in some manner that isn’t
be parts of the United States
understood today while removwhere you have a lot of ticks, but
ing the threat that they pose to
infection is not very high. This
human populations.
“Especially for the parasitic
protozoans, which have few
convenient antibiotic cures,
targeting the vectors themselves is a promising route for

is also the case with mosquitoes
in India. Many factors, intrinsic
and extrinsic, influence infection prevalence—this is complex.
We wanted to examine whether
the tick gut microbiome might
represent one factor, and if
shifts in the tick’s microbiome
might contribute to the tick’s
ability to host and transmit
the pathogens.”
Research conducted by several groups into the lives of
African mosquitoes suggests
that mosquitoes’ gut microbiota influence the survival of
their malaria-causing parasites.
Articles published in the last
decade uncovered correlations
between bacteria present in
arthropods like Aedes aegypti
and resistance to such deadly
pathogens as (in the case of
Aedes aegypti) the dengue virus.
Narasimhan and Fikrig’s
efforts indicate that the microbiome of ticks does play some role
in ticks’ “health” in the context of
how they acquire pathogens and
how they molt, but the researchers are still working to establish
the precise nature of that role, as
well as which microbiota or subset of microbiota observed in ticks
might play a significant role.
Ultimately, Fikrig and
Narasimhan hope that if we
understand how the tick microbiome influences tick-borne
pathogens, it may be possible to
leverage that knowledge to reduce
the prevalence (if not the virulence) of tick-borne diseases.
Serap Aksoy, PhD, FW ’88,
professor of epidemiology

G E T T Y I M AG E S

(microbial diseases) in the Yale
School of Public Health, has
battled the protozoan parasites
that cause African trypanosomiasis (more commonly known
as “African sleeping sickness,”
which is fatal if untreated) for
decades. Her research into the
insect vector primarily responsible for spreading the disease—
the tsetse fly—has resulted in
numerous breakthroughs: most
recently, a mechanism that
reduces the fly’s ability to transmit
disease-causing trypanosomes.
“One of the more interesting characteristics of the tsetse
fly is its mode of reproduction,”
says Brian Weiss, PhD, FW ’08,
research scientist and lecturer
in epidemiology (microbial diseases) in the School of Public
Health. Weiss, who works in
Aksoy’s lab, knows a great deal
about the topic. “Tsetse flies
reproduce through a process
called adenotrophic viviparity, which means gland-fed live
birth. In this situation, embryonic and larval stages (one
per reproductive cycle) occur
within the mom’s uterus, and
the larva receives nourishment
in the form of milk secreted by
a modified accessory gland.” In
contrast, almost all other female
insects will lay a clutch of fertilized eggs into their environment
and hope that a couple of them
reach sexual maturity.”
Aksoy and her research team
discovered that tsetse milk also
contains symbiotic bacteria that
mediate numerous aspects of the
fly’s physiology. One of these

microbes, the Wigglesworthia
species (named after the famous
British entomologist who first
described it) shares an obligate
association with its tsetse host.
Without Wigglesworthia,
which produces essential nutrients missing from tsetses’
vertebrate blood specific diet,
adult flies present a severely
compromised immune system
and are reproductively sterile.
This research provides useful
insights for developing control
strategies aimed at reducing
tsetse population size and/or
inhibiting the fly’s ability to
transmit trypanosomes.
Tsetse flies house other
symbiotic bacteria that may
also reduce disease transmission. “Most tsetse flies harbor a
commensal bacterium from the
genus Sodalis (which means
‘companion’ in Latin) that, similar to Wigglesworthia, is passed
from mother to larva via milk.
This bacterium can live outside
of its host and be genetically
modified. If we can customize
Sodalis to produce a trypanocidal protein, and then return
these bacteria to the fly, they
may become more resistant to
infection,” says Aksoy. These
characteristics make Sodalis an
attractive target for research.
“We’ve designated insects
that carry genetically modified
symbionts as ‘paratransgenic,’ ”
says Aksoy. “And one of these
days, they might help wipe out
some of humanity’s most prolific killers.”
—Adrian Bonenberger

»

Turning the page:
The transformation of
the Medical Library
When John Gallagher, the director of the Cushing/Whitney
Medical Library (CWML), arrived
at Yale nearly two decades ago,
the bustling information hub of
Yale School of Medicine actively
received 2,600 individual scientific journal titles in print format.
The newest journal issues were
shelved in the Morse Reading
Room, while older issues, bound
in volumes, occupied entire floors
of space in the journal stacks on
the basement level. Researchers
photocopied articles and library
staff reshelved thousands of
bound volumes each week.
But there was a digital revolution in the offing: within five
years, that list of 2,600 titles had
dwindled to around 100. It has
continued to drop; these days,
the library receives just a handful
of print journals. Students and

Part of the effort to
stop diseases involves
protecting humans
from infection. Rather
than killing vectors
with such ecologically
harmful procedures
as spraying against
mosquitoes or ticks,
another approach researched in places like
Yale involves protecting those insects from
the diseases they carry.
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A recent graduate
of Yale is working on
blended and augmented reality technology
in cooperation with
YSM faculty, that could
revolutionize how
patients with problems
seeing (such as the
blind) interact with
their surroundings.
For more on blended
and augmented reality
technology, visit ymm.
yale.edu/blendedreality
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researchers, however, have never
had greater access to biomedical
literature, as they now have digital access to some 23,000 librarylicensed journals. The fact that
these journals take up virtually
no room has been a game-changer
for CWML and YSM.
“The transition from print to
electronic has freed up an enormous amount of space, and it’s
given us a chance to think about
the best way to use it,” says
Gallagher. “This has been a great
opportunity and we’re really
excited about it.”
The library teamed with
Richard Belitsky, MD, HS ’82,
FW ’83, the Harold W. Jockers
Associate Professor of Medical
Education and deputy dean for
education; Michael Schwartz,
PhD, associate dean for curriculum and associate professor of
neuroscience; and other administrators at the medical school to
come up with an innovative project that marries the library’s core
mission as a center of learning
with ongoing curriculum reform.
Signs bearing the image
of “Hard Hat Harvey” Cushing
began appearing in the library’s
halls and on its website last
summer. Since then, the quiet
is sometimes broken during
the day by Petra Construction
Corporation workers tasked
with gutting and transforming
much-used and now cordonedoff areas of the first floor, basement, and sub-basement. (Many
sections of CWML, such as the
Morse Reading Room and the
Historical Library, are not part

of the renovation.) When the last
literal hard hats finish up work in
June 2019, the reengineered space
will be home to a team-learning
classroom that can accommodate
Schwartz. “Our new curriculum
120 students; eight smaller classreflects this reality, and the new
rooms; a quartet of group-study
classroom gives us an effective
rooms; and an information comspace for helping our students
mons equipped with 30 comdevelop the perspective and
puter workstations, a faculty
expertise to work this way.
video-production studio, and the
Learning is less about facts and
offices of several librarians.
more about the process of evalu“Our students come from an
ating and applying information,
era in which they have rapid
so it makes a lot of sense to cenaccess to information, a high
ter this in the library.”
reliance on technology, and an
The renovated spaces also
emphasis on interactive learnare designed to better impleing,” says Belitsky, “and the
ment a team-based interactive
curriculum we implemented in
approach, and the planners were
2015 is designed to reflect that.
But if you change your pedagogy, mindful of crafting a facility
that would be flexible and useful
you need different spaces that
to the wider School of Medicine
can better carry out these new
community after the students
ways of teaching.”
leave the rooms. “The challenge
The old model—the learned
was adopting the area for teachprofessor standing at a lectern
ing while at the same time preand dispensing wisdom to acoserving the history and charm of
lytes frantically scribbling down
the library,” says Schwartz.
every fact—has been set aside
The result will be a suite of
in favor of the “flipped curricuplaces that can serve as both
lum” model. This model requires
classrooms and after-class spots
a team-learning classroom in
for study; such community eduwhich students gather around
cation opportunities as lectures
tables in groups of about a half
and seminars; and social gatherdozen. Medical students will
ings. The library still acquires and
have already read and mastered
shelves books and remains home
an assignment or absorbed a
to one of the world’s most impresprofessor-created video, and
sive medical-historical collections.
they’ll come to class to work with
“When this is done, we’ll be able to
their peers on projects overseen
connect people with information in
by their teacher, to implement
ever more sophisticated and effecwhat they’ve learned, and to share
tive ways,” explains the Medical
and debate their ideas in real time.
Library’s associate director, Holly
“Medicine today is a
Grossetta Nardini, “and we’ll preteam-based endeavor,” notes
serve the kind of serendipity that
often results when people interact.”
Adds Schwartz: “This is a
nice win-win partnership.”
—Bruce Fellman

a collection of recent
scientific findings

SUICIDE RISK IN THE GENOME

G E T T Y I M AG E S

People have long understood that having a suicide in one’s family elevates other
members’ risk of suicide in ways that
haven’t always been tangible or understood. Now, scientists at Yale, including
Joel Gelernter, MD, the Foundations Fund
Professor of Psychiatry and professor of
genetics and of neuroscience, and Daniel
Levey, PhD, have identified genes linked to
suicide attempts in different U.S. populations. They hope to broaden the investigation by evaluating data collected through
the Department of Veterans Affairs’
Million Veterans Program (MVP). The
suicide rate among veterans has grown in
recent years, and reducing it is a priority
for health care administrators.

ELECTROSPRAY INNOVATION
DRIVES SCIENTIFIC ADVANCES

GIVING THE ELDERLY
THEIR VOICES BACK

IN-PERSON SOCIAL NETWORKS
AFFECT THE MICROBIOME

At the University of Minnesota in 1911, physicist John Zeleny, who also worked at Yale
during World War I, developed an apparatus called “electrospray” to study electrical
discharge in gases. Electrospray involves
driving fluid through a tiny aperture; the
resulting mist can then be evaluated at the
molecular level. Alessandro Gomez, PhD,
and Juan de la Mora, PhD, both professors
of mechanical engineering and materials
science, continue this line of inquiry. One
successful collaboration involved working
with the lab of Tarek Fahmy, PhD, associate
professor of biomedical engineering and
immunobiology, to synthesize nanoparticles for the delivery of cancer drugs.

The Department of Emergency Medicine
at Yale School of Medicine is working on
a project designed to serve a traditionally underserved and systematically
exploited population: the elderly. One in
10 Americans over the age of 60 is mistreated in some way, and VOICES (Virtual
cOaching in making Informed Choices
on Elder mistreatment Self-disclosure),
funded by a $1.5 million grant from the
National Institute on Aging, will help victims report physical, emotional, financial,
or sexual abuse and seek assistance.

As scientists investigate the human
microbiome, efforts are underway to
step back and understand how various
human microbiomes affect each other
during face-to-face social interactions.
Led by Nicholas Christakis, MD, MPH,
PhD, Sterling Professor of Sociology, and
funded by a $3.54 million grant from the
NOMIS Foundation, the Microbiome
Biology and Social Networks in the
Developing World project will gauge how
our friends’ and relatives’ health affects
our own—on a bacterial level. When Mom
said, “Wash your hands before dinner,”
she wasn’t saying it just for your own
good, but for hers too!
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Mental health and its opposite

TH E TH I R D E D ITI O N of the Diagnostic and Statistical Manual of Mental Disorders,
published in 1980, was the first to describe psychopathy as antisocial personality disorder (or APD/ASPD). This diagnosis depended on decades of studies, professional conversations, and advances in neuroscience and technology. Eventually, scientists determined
that the condition is neither a moral failing nor (for the most part) a failing of society,
but rather the result of a combination of genetic and social influences. Since 1980, the
standard by which professional physicians judge whether someone is a psychopath has
expanded but not changed fundamentally. Meanwhile, researchers have inched closer to
understanding the underlying causes of mental disorders in people previously described
as “crazy” … and how to treat those causes.
An evolving idea of what drives mental illness informs mental wellness. And a great
many advances in that field are unfolding at Yale School of Medicine. Phil Corlett, PhD,
FW ’10, and Albert Powers, MD, PhD, HS ’16, use research with psychics to better understand the root causes of hallucinations common in schizophrenia. Lynnette Averill,
PhD, FW ’15, is involved in trials overseeing the prescription of ketamine to heal patients
suffering from post-traumatic stress disorder, expanding on pioneering research conducted by John Krystal, MD ’84. Emma Lo, MD, a fourth-year resident in the department
of psychiatry, takes this research and applies it on the clinical level to a population that
disproportionately suffers from mental illness, people experiencing homelessness.
These stories and more examine experts’ role in triangulating the causes of diseases and genetic conditions. Resolving biological mysteries is at the heart of contemporary mental health research. So much of what’s exciting in the field involves technological advances at Yale that pose new questions and answer old ones.
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Rethinking
mental illness
A look at the state of mental health and its inverse,
mental illness, from prominent Yale School of
Medicine faculty and researchers from the departments of psychiatry and neuroscience.
by steve hamm

Albert Rivera has had a hard-luck life. As a child, he
experienced physical and emotional abuse. Now 38
years old and living in New Haven, he suffers from
post-traumatic stress disorder (PTSD) and is in recovery from alcohol and opioid abuse. To top things off,
he’s in transitional housing—without a dependable roof
over his head.
Yet Rivera has hope for his future. He holds a job and
he stays on an even keel by participating in two programs
run by Yale School of Medicine. One helps people with
mental illnesses deal with the stresses of life, and the
other enables them to play positive roles in the community.
“They help me cope,” Rivera says. “They gave me a purpose
and made me part of something bigger than myself.”
The programs are examples of an emerging trend
in the treatment of mental illnesses called recoveryoriented care and citizenship. The idea is that helping
people cope with their illnesses and live productive
lives as valued members of their communities is an
essential part of their care—alongside medications,
talk therapy, and other treatments.
Recovery-oriented care and citizenship are part of
a major rethinking of mental illness and care that is

now underway nationwide. Until recently, the primary focus among mental health professionals has
been on identifying therapies that suppress the symptoms of disease and administering those therapies
in a clinical setting. Increasingly, though, researchers are focusing on understanding the core causes
and mechanisms of mental illness, and clinicians are
helping their patients grapple with the social determinants of health while developing a sense of belonging in their communities.
In a sense, mental health care is being redefined—
becoming ever more precise and personalized in
the biological research sphere and more holistic and
patient-centric in the way treatment is provided.
“We need to think differently about psychiatry than we
have in the past,” says John Krystal, MD ’84, HS ’88,
the Robert L. McNeil, Jr. Professor of Translational
Research, professor of psychiatry and of neuroscience,
chair of the Department of Psychiatry at Yale School of
Medicine, and chief of psychiatry at Yale New Haven
Hospital. He believes the department will play a significant role in advancing science, improving care, and
training the next generation of leaders in the field.
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Progress is sorely needed. That’s because the state
of mental health in the United States is poor. Nearly
20 percent of the population, or about 60 million people,
suffer from some type of mental illness each year. More
than 24 million people struggle with substance abuse.
The treatment of mental illness has undergone
waves of change over the past 100 years. The field was
defined in the early- to mid-20th century by mass
institutionalization, poorly informed use of lobotomies,
and the dominance of psychoanalysis. Over time, those
approaches gave way to deinstitutionalization, rapid
proliferation of drug treatments, cognitive behavior
therapies, and now psychosocial interventions, including recovery-oriented care.
Understanding of the causes of mental illness has
evolved as well. Psychiatry pioneer Sigmund Freud
posited that mental illness is caused by conflicts
between different parts of the mind resulting from
childhood trauma. Later, leaders in the field came to
believe that mental illness is the result of disruptions
in biological processes. Now psychiatrists increasingly recognize the powerful impacts poverty and
other traumatic life experiences have on mental health.
“Each view has enriched the picture. They complement
each other in explaining mental illness and fostering new treatment directions,” says Michael Sernyak
Jr., MD, HS ’91, professor of psychiatry and CEO of
Connecticut Mental Health Center (CMHC).
Yale has long been recognized as a national leader in
psychiatry. Today its psychiatry department is one of
the largest in the country, with more than 350 faculty
members. Yale’s partnership with the VA Connecticut
Healthcare System has produced numerous advances in
PTSD treatment. Its joint venture with the state in CMHC
provides psychiatric care for more than 5,000 economically disadvantaged people each year. Yale Child Study
Center is renowned for research and clinical care. And
the Interventional Psychiatry Service at Yale New Haven
Psychiatric Hospital is a leader in providing people with
severe mental illness with access to the latest experimental treatments.
new directions in the biology of mental illness
Breakthroughs in understanding human biology in the
mid-20th century led to the development of medications
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for mood disorders and psychosis—alleviating suffering
for millions of people. Yet most of the “wonder drugs”
introduced during that era addressed the symptoms
rather than the causes of disorders.
A new wave of biological research spanning neuroscience and genetics is deepening our understanding
of mental illness’s underlying biology. This research
promises to deliver a new generation of medications
and treatments that target causes. “This is opening up
a whole host of new treatment options,” says Gerard
Sanacora, MD, PhD, HS ’98, FW ’99, the George D. and
Esther S. Gross Professor of Psychiatry and director of
the Yale Depression Research Program.
One of the major breakthroughs in this area came
in the 1990s when Krystal and colleagues discovered
that the drug ketamine, an anesthetic, could provide a
fast-acting treatment for depression. Previously, antidepressants had focused on suppressing unruly chemicals in the primitive parts of the brain. But ketamine
targets the chemical glutamate in the neocortex, where
memory and thought reside. The drug treats a cause
rather than a symptom. The hospital now offers experimental ketamine infusion therapy for depression.
These days, research labs within the School of
Medicine are using neuroimaging and genetics to probe
deeper into the workings of the brain. One lab, run
by Ronald Duman, PhD, FW ’88, the Elizabeth Mears
and House Jameson Professor of Psychiatry, professor
of neuroscience, and director of the Abraham Ribicoff
Research Facilities at CMHC, has been studying ketamine
to better understand the pathophysiology of depression.
His team discovered that for some individuals, chronic
stress and depression cause atrophy and loss of synapses,
reducing connectivity in the brain. Ketamine promotes
the growth and vitality of synapses. “We’re learning
more about how the brain works,” says Duman.
One of the team’s primary goals is to discover
alternative therapies to ketamine that don’t carry the
drug’s negative side effects, such as hallucinations.
As researchers probe the brain, they’re making discoveries that may lead to a reclassification of mental illnesses.
Today, psychiatrists refer to the Diagnostic and Statistical
Manual of Mental Disorders, fifth edition (DSM-5) to
make their diagnoses. Its classifications of disorders are
based primarily on observations of behavior. Increasingly,

researchers find that the phenomena they observe in the
brain do not line up with DSM diagnoses. There’s too much
overlap to separate these phenomena into strict categories.
As research advances, it may turn out that many illnesses
have the same causes, such as stress and inflammation—
leading to new treatment strategies.
Because of the ever-increasing role of neuroscience in psychiatry, the Department of Psychiatry’s
residency program has evolved to include training in
applying neuroscience to clinical practice. “The goal
is to help clinicians arrive at more accurate diagnoses

helping patients live in the world
In 1977, two women in Madison, Wis., Harriet Shetler and
Beverly Young, met for lunch to discuss the challenges
faced by their sons, who had been diagnosed with schizophrenia. That fateful meeting marked the beginning of the
mental-health patients’ advocacy movement, which has
pushed the psychiatric community to provide care that
respects patients’ rights and wishes. Out of that shift in
perspective came recovery-oriented care.
The core idea is that people with mental illness can
recover even though they’re not “cured.” They can live

		Chyrell Bellamy

“We need leaders with lived experience
at the table so that we can together
		 transform health care organizations.

and to communicate better with patients about what’s
going on,” says David Ross, MD ’05, PhD ’04, associate
professor of psychiatry, who led the initiative.
Rather than relying on traditional lectures, the
curriculum includes videos, interactive exercises, and
resources for self-directed study.
Ross, working with colleagues at Columbia
University and the University of Pittsburgh, discovered that few residency programs around the country
were incorporating neuroscience into how they taught
psychiatry. To address that gap, Ross’ group created the National Neuroscience Curriculum Initiative
(NNCI), which offers a comprehensive set of teaching and learning resources, many of which were first
implemented at Yale. Today, more than 100 residency
programs use the curriculum, and the website has
36,000 registered users from 153 countries.

satisfying lives—holding jobs, enjoying their families,
and contributing to society. “These interventions are
aimed at the recovery of daily function and life. The
focus is on helping a person have the kind of life they
want,” says Larry Davidson, PhD, FW ’92, professor of psychiatry and director of the Yale Program for
Recovery and Community Health (PRCH).
His organization does research, training, and policy
development aimed at equipping health care and social
service agencies to support recovery-oriented care.
It also runs experimental programs in New Haven that
provide direct support for patients—including personcentered care planning and community-based recovery programs.
The ultimate goal of recovery-oriented care is achieving wellness—improving mental and physical health by
expanding awareness and making better choices in all
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dimensions of life. Wellness is not the absence of illness
or stress; it’s making the best of one’s situation.
Citizenship adds another dimension, recognizing
the rights, responsibilities, roles, resources, and relationships necessary for contributing to community on
one’s own terms, often through involvement in collective endeavors.
A lot of the work being done at PRCH is practical
and utilitarian. The programs help people get jobs and
diplomas. CMHC, for instance, provides bicycles for
some of its low-income patients, enabling them to get
to appointments and jobs on time, and improving their
physical fitness and self-esteem.
There’s also a strong emphasis on heeding the
wishes of the patient. For instance, a person may
choose to forgo a medication that suppresses their
symptoms because it also makes them groggy, interfering with their ability to work and socialize.
A key element in such programs is the role of peers—
individuals who have experienced mental illness and/
or substance abuse who advise and guide patients as
they navigate their recovery. A peer-support staff
member in New Haven, Richard Youins, helps run a
weekly discussion group at CMHC and coordinates
Magicians Without Borders, which teaches people
magic tricks they can use as icebreakers when they
tell their stories in public. “When I was in addiction,
if somebody had told me I would someday have
a job where I was doing good things for other people,
I would have laughed. But it happened,” he says.
“We’re all walking, breathing possibilities.”
Studies of the PRCH programs have shown that peer
support reduced hospital readmissions by 42 percent,
reduced hospital stays by 48 percent, and improved
relationships with health care providers.
The School of Medicine is also helping people in
recovery play roles in reforming the mental health care
system. Lived Experience Transformational Leadership
Academy, a nine-month training program, prepares
people to develop and enhance their capacity for
leadership. “We need leaders with lived experience
at the table so that we can together transform health
care organizations,” says Chyrell Bellamy, PhD, MSW,
associate professor of psychiatry and director of Peer
Services and Research at PRCH.

16

ymm.yale.edu

In order to equip future psychiatrists to provide
recovery-oriented care, the Department of Psychiatry
has developed a robust social justice and health equity
program within the residency curriculum. “We can
predict more about a person’s health from their ZIP
code than their genetic code, so we need to train residents about implicit bias and the roles of communities
in mental health,” says Robert Rohrbaugh, MD ’82,
HS ’86, FW ’88, professor of psychiatry and deputy
chair for Education and Career Development.
The social justice and health equity program takes residents out of the classroom and clinic into New Haven’s
neighborhoods, where they learn how such factors as
housing, employment, transportation, and neighborhood
gardens can be barriers to health or help improve it.
For Hana Ali, MD, a second-year resident, the program was a revelation. A guided tour last year of the
New Haven neighborhood where she lived took her
under the surface to understand the experiences of her
neighbors. “It told me there are lived experiences of
the patient we take care of that we have no idea about.
In order to care for a person, you need to get a full
sense of them—what their lives are like,” she says.
Along both vectors where mental illness is being
rethought, the biological and the behavioral, researchers and clinicians are gaining knowledge rapidly.
“It is wonderfully stimulating to work in a community
where the issues arising from basic science, the
clinic, and the community converge,” says Krystal.
Huge challenges remain. The mechanisms of the
brain are amazingly complex and difficult to interpret.
The interactions of individuals with others and society
are so varied. There are many stressors in modern life.
Yet School of Medicine faculty members are
optimistic that new scientific discoveries and new
approaches to treatment will improve the lives of those
who suffer from mental illnesses. “We’ll have breakthroughs. It’s what we are as a species,” says William
Sledge, MD, HS ’75, the George D. and Esther S. Gross
Professor of Psychiatry Emeritus, who was for many
years the medical director of psychiatry at the hospital.
“We will find a way.” /yale medicine magazine
Steve Hamm is a frequent contributor to Yale Medicine Magazine.

Armoring the psyche:
A brain’s resilience
Studies indicate that people whose brains are
“wired” for resilience can also receive training that
further fortifies them against psychiatric trauma.
By John Altavilla
What makes one human predisposed to suffer from stress and another comparatively
immune? Doctors, researchers, and philosophers have wrestled with this question for
decades. Answers have been hard to come by, and are anecdotal at best.
Rajita Sinha, PhD ’92, the Foundations Fund Professor of Psychiatry, professor in
the Yale Child Study Center, and professor of neuroscience, has long been fascinated
by the fickle nature of mental fortitude. Her studies focus on the characteristics of
the brain that determine resilience.
Sinha believes she has found the answer. Working with colleagues, she assessed the brains of 30 subjects who presented no prior physical or emotional
issues. The subjects were exposed to horrific images for a few minutes, then to
photos unlikely to provoke an emotive response.
Her study revealed how the brain reacts under stress, and what it does to
adapt and be resilient in response. Findings show brains have a specific resilient
coping circuit involving a key medial prefrontal region tucked behind the forehead,
which slowly activates during stress (such as exposure to grotesque visual images) and helps calm other stress responses. Brains that demonstrated this signal
during testing exhibited resilient coping behaviors. Those without the signal
tended to engage in nonresilient behaviors for coping, such as avoidance (deferring or evading an unpleasant task or event that evokes previous trauma).
This finding provided an explanation as to why some people may exhibit greater
innate resiliency. Those people may be wired to respond effectively to stress, while
some others aren’t. The benefits extend to training: These brain regions can learn and
be trained to increase that capacity.
“There are certain basic things we know that work for the brain, if you think
about resilience. We know that having warm, loving parents is absolutely necessary for a developing brain,” says Sinha. “Studies have shown that trauma and
neglect, both emotional and physical, are not good for the brain.”
Resilience is one’s ability to recover from a horrible injury, tragedy, or exposure
to stressors. Those who are resilient are better able to endure hardship. Those without this characteristic are more likely to develop such stress-related illnesses as depression, anxiety, obesity, heart disease, addiction, and even some types of cancers.
Psychological resilience correlates with positivity, and training oneself to
think positively increases one’s innate resistance to anxiety and depression.
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Breaking the cycle of
traumatic memories
Trials offering ketamine doses to patients suffering from
post-traumatic stress disorder give some veterans hope
that they can live a normal life.
by courtney mccarroll

After returning home from active duty, soldier Bassheva
Trenk felt as though something significant had shifted
inside. Afflicted with intense despair, tortured by lack of
sleep and vivid nightmares, Trenk was unable to function
in her everyday life. Even a trip to the grocery store left
her feeling on edge, hypervigilant, and fearful of anyone
standing too closely behind her in the checkout line.
“When I got out of the Army, I was in a state of
complete misery. I had no idea how I was going to get
through,” says Trenk. Removed from the comfort and
familiarity of home and reeling from the effects of
trauma, Trenk struggled considerably.
Even under ideal conditions, military service takes a
toll on one’s mental health. War, combat, toxic leadership, and other traumas all challenge the wellness of
service members and—unfortunately—are not uncommon. Coupled with an individual’s mental makeup prior
to enlistment, prolonged periods of extreme mental,
emotional, and physical stress can increase the risk of
developing post-traumatic stress disorder (PTSD).
Although PTSD can manifest in a multitude of ways,
this debilitating anxiety disorder is typically triggered
by an especially harrowing event—usually one that the
victim experienced directly or witnessed firsthand.

Memories or flashbacks of the event can haunt victims,
leaving them feeling endangered, irritable, and afraid.
The disorder can be so debilitating that for some, suicide seems like the only recourse. According to the U.S.
Department of Veterans Affairs, 20 military veterans
commit suicide on an average day—the majority of
whom are veterans of the Vietnam War.
In her darkest hour, Bassheva Trenk came dangerously close to enlarging that tragic number. Fortunately,
her attempt was forestalled. After Trenk recovered, a
close friend begged her to seek help and graciously
offered to cover Trenk’s living expenses until she could
get back on her feet. This act of generosity allowed Trenk
to find her way to Tim Amoroso, a staff affiliate of the
VA Medical Center (VAMC) in West Haven.
Down the hall from Amoroso’s office, buried deep
within the sprawling VA Connecticut Healthcare
complex, flyers and pamphlets adorn the corkboard
and visitor seating area, offering relief to veterans
afflicted with treatment-resistant PTSD. Funded in
part by the multi-institutional Consortium to Alleviate
PTSD (CAP) and in partnership with the VA and
Yale University, a team of researchers that includes
Amoroso investigates a novel approach to treating the
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disorder. It is one of the first clinical trials in the country to evaluate the effectiveness of ketamine, an anesthetic most commonly used in veterinary surgery, as
part of PTSD therapy.
The CAP study traces back to a significant
breakthrough made in the 1990s by John Krystal,
MD ’84, HS ’88, the Robert L. McNeil, Jr. Professor
of Translational Research, professor of psychiatry
and of neuroscience, and chair of the Department
of Psychiatry. Along with his colleagues at the time,
Krystal discovered that ketamine has substantial and
rapid effects on patients suffering from major depression. Later, Ronald Duman, PhD, FW ’88, the Elizabeth
Mears and House Jameson Professor of Psychiatry and
professor of neuroscience; and George Aghajanian,
MD ’58, HS ’61, FW ’63, professor emeritus of psychiatry, found that ketamine’s efficacy lies in its remarkable ability to restore synaptic connections in the brain.
Dennis Charney, MD, HS ’81, conducted a pilot study
suggesting that ketamine may also reduce the symptoms of PTSD. With these pieces in place, the present
CAP study was born.
Amoroso—a former Army Ranger (2-75th)—is
recruiting active-duty personnel and veterans
between the ages of 18 and 70 who have been diagnosed with PTSD but have had little success with
their prescribed antidepressants. His goal is to enroll
100 participants. After they are cleared for the study,
participants are then randomized into three separate
groups: a placebo group (which receives a saline infusion); a low-dose group (which receives 0.2 mg/kg
of ketamine); and a high-dose group (which receives
0.5 mg/kg of ketamine).
When participants like Trenk attend their infusion
appointments at the VA, they are asked to complete a
handful of surveys to establish their baseline mood and
demeanor that day, participate in an interview, and
discuss any notable side effects or adverse events since
their last session. Once approved by the VA doctor on
staff, their infusion begins; it lasts about 40 minutes.
“Ketamine is safe, well tolerated, and has a relatively minor side-effect profile (compared to the
traditionally available antidepressants),” explains
Lynnette Averill, PhD, an associate research scientist
in psychiatry and member of the VA research team.
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“I’ve seen people change before my eyes after an infusion—the tension in their face changes, their affect
changes, and the next day they are hardly recognizable. It’s exciting and rewarding work to witness this
and be part of their journey.”
Chadi Abdallah, MD, FW ’13, assistant professor
of psychiatry, and his colleagues are very optimistic
about the study thus far and look forward to assessing the comprehensive results in 2020. Ketamine’s
potential to create positive change in people’s lives is
enormous. “The success of the [study] may show that
ketamine could be safely and effectively administered
to veterans suffering from refractory PTSD,” says
Abdallah. “It may potentially provide the required evidence to expedite the implementation of this investigational treatment across the VA health system.”
Although no longer in the study, Trenk still undergoes infusions once every month or so (in combination
with her antidepressant medications), she credits ketamine with several positive changes. She reports being
able to sleep more soundly, has noticed a significant
reduction in the frequency and severity of her anxiety,
and has even enrolled in a general-studies program at
her local community college. With renewed confidence,
Trenk has set her sights on a bright future.
“Ketamine has had an obvious impact on my life.
When the effects start to fade away and my anxiety
and aggression return, that’s how I know how big of
an impact it has had. I’m not 100 percent recovered,
but I’m doing so much better now.” /yale medicine
magazine
Courtney McCarroll is a writer, and works as a program coordinator
in Yale’s development office.

Post-traumatic resilience
In U.S. veterans, social connectedness, optimism,
and a sense of purpose are among the
characteristics associated with bouncing back from
trauma—sexual and otherwise.
By Ashley P. Taylor
Many think the biggest threat to military personnel is battlefield death or injury.
While that is certainly true during wartime, the military spends much of its time
training. And for U.S. veterans, sexual assault confers a greater risk of post-traumatic
stress disorder (PTSD) than combat.
Robert Pietrzak, PhD, MPH, associate professor of psychiatry and director of
the translational psychiatric epidemiology laboratory of the clinical neurosciences
division of the National Center for PTSD in West Haven, studies veterans, PTSD, and
resilience. According to his research, sexual assault comes with a 26 percent likelihood of developing PTSD if the trauma occurred during childhood and 36 percent if
the trauma occurred during adulthood. About 10 percent of veterans have experienced sexual assault, the trauma most strongly associated with PTSD. In comparison, combat of any kind—which about 35 percent of veterans have experienced—
comes with an approximately 19 percent risk of developing PTSD. However, this
figure increases as a function of the intensity of the combat exposure—the most
heavily exposed veterans have a 35 percent likelihood of developing PTSD.
These data about veterans, PTSD, and resilience come from the National
Health and Resilience in Veterans Study (NHRVS), which Pietrzak and his colleagues have been conducting since 2011. In the NHRVS, nationally representative samples of thousands of veterans answer survey questions designed to learn
about veterans’ experiences with trauma, PTSD symptoms, and other factors.
Researchers then analyze the data to determine which factors are associated with
PTSD and which with resilience, or the ability to “bounce back” from trauma.
In addition to having experienced such types of trauma as sexual and physical
assault, other factors that increase the risk of PTSD include being of younger age
and female.
Nevertheless, many veterans rebound from their ordeals. Among veterans exposed to high levels of trauma of any kind, 70 percent are psychologically resilient;
in other words, they do not exhibit symptoms of PTSD, depression, or anxiety.
“They basically look as if they hadn’t been exposed to trauma at all,” says
Pietrzak. His research investigates why it may be possible to use that knowledge
to help others to bounce back.
Among veterans who participated in the NHRVS in 2011, those who felt they
had strong social support and a sense of meaning and purpose in life were less
likely to develop symptoms of PTSD, depression, or anxiety. Optimism and gratitude also correlated with greater ability to recover from these symptoms.
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Taking psychiatric
help to the street
by steve hamm

22 ymm.yale.edu

Last August, New Haven made the national news in a
way no city wants when 72 people were poisoned by an
illicit synthetic cannabinoid called AMB-FUBINACA.
All over the New Haven Green, people who had ingested
and/or inhaled the substance fell to the ground, convulsed, and lost consciousness.
Among those who rushed to help them was Emma
Lo, MD, a fourth-year resident in Yale School of
Medicine’s psychiatry program and volunteer with a
street medicine team.
Ambulances, police, and EMTs were scattered all
over the green when she arrived. She knelt to aid a man
who had just fallen and was seizing. After a moment,
she recognized him as a former patient of hers at the
Connecticut Mental Health Center (CMHC), where she
had completed a residency rotation. Thinking that
he was suffering an opioid overdose, she sprayed the
emergency antidote naloxone up his nose. It didn’t
work. “I felt very helpless. I wanted to save him, but
we didn’t know what was going on,” Lo says.
Luckily, nobody died. But stunned city government and health care officials developed a strategy for
avoiding a repeat of that awful day. A number of the
overdose victims were homeless, so the official response
included creating one of the few street psychiatry teams
in Connecticut and hiring Lo to spearhead it. “We’re
developing a program that can be scaled up if it’s proven
to be effective,” says Jeanne Steiner, DO, medical director of CMHC and associate professor of psychiatry at
Yale School of Medicine.
Lo has shown a deep concern for people experiencing homelessness ever since she began volunteering to
help them as an undergraduate at Haverford College.
“In New Haven, we’re lucky to have a wealth of
resources for people who live on the street, but there’s
a gap for people who are chronically mentally ill,” she
says. “There are clinics that offer mental health care
but until now there was nobody going out to provide
care where the people are.”
While national experts estimate that about 25 percent of the homeless population suffers from severe
mental illnesses, those who care for them say nearly all
have some sort of mental disorder. “Some are homeless because of mental illness, and some are mentally
ill because of the stress and trauma of homelessness,”

says Philip Costello, an advanced practice registered
nurse who is the clinical director of homeless health
care outreach for New Haven’s Cornell Scott-Hill
Health Center.
Lo had been volunteering on Costello’s team for two
years as they provided basic medical care for people
experiencing homelessness—in parks, at soup kitchens,
at shelters, and on the street. Costello says Lo has a
low-key style that breaks down the barriers of distrust
that many homeless people have for police and health
care professionals alike. “These people are so marginalized and they only warm up to somebody who has
the persona to be sensitive, genuine, and patient—and
Emma is all of those things,” says Costello.
Lo credits the residency program’s practice of setting aside time for special projects with helping her
get to where she is today. She crafted her own residency rotation with the street medicine team. Now,
thanks to her, street psychiatry is an elective rotation
for other residents.
Her journey is part of a major new emphasis in the
psychiatry residency program—where social justice
and health equity are increasingly baked into the curriculum. Residents interact with patients and community leaders throughout New Haven’s neighborhoods.
To raise their awareness, the residents even try to buy
healthy meals with the $2.10 per meal that the government provides for food assistance. “We’re exposing the residents to structures in the community that
affect health so they better understand the issues their
patients face, can help provide more comprehensive
patient care, and can advocate for change,” says Robert
Rohrbaugh, MD ’82, professor of psychiatry and residency program director.
“Every resident could benefit from this experience,”
Lo says. “It has taught me so much about understanding people—not just their physical and mental health
but their whole environment, the social determinants
of health. Ultimately, you’re learning empathy.”
/yale medicine magazine
Steve Hamm is a frequent contributor to Yale Medicine Magazine.
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Brain bank aids theories
on genetics and posttraumatic stress disorder
by jenny blair, md
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Brain bank aids theories on genetics and post-traumatic stress disorder

Yale researchers use a massive brain-tissue repository,
or “brain bank,” at the VA’s National Center for PTSD to
postulate generalizations about the genetic origins of
the condition and its physiological characteristics.

The nightmarish experience of post-traumatic
stress disorder (PTSD) may be as old as danger itself.
Survivors of natural disaster, criminal and domestic
violence, and combat or granted formal psychiatric
designation only in 1980. PTSD continues to pose a
formidable challenge to treatment. Guidelines are
derived more often from expert opinion than from
trial results and only two medications were FDAapproved as of late 2018.
Now, drawing on a “brain bank” as well as a
massive study of veterans, researchers at the School
of Medicine are mapping PTSD’s genetic and neurobiological underpinnings. Their efforts could
help predict who is susceptible, point the way to
better treatments, and perhaps teach people how
to cultivate resilience.
The aim of these studies is to move from the
art to the science of psychiatry, says John Krystal,
MD ’84, HS ’88, the Robert L. McNeil, Jr. Professor of
Translational Research, professor of psychiatry and of
neuroscience, chair of the Psychiatry Department, and
director of the Clinical Neuroscience Division of the VA
National Center for PTSD. To date, most PTSD research
has been psychological, not biological, so the field has
some catching up to do.
“Almost everything that we’re doing is the first of its
kind,” Krystal says.
These studies are not merely groundbreaking,
they’re vast in scale. So far, some 600,000 veterans
have contributed DNA to the nationwide Million
Veteran Program (MVP). With this database—one of
the world’s largest—researchers can detect subtle signals across thousands of genes.

26 ymm.yale.edu

Joel Gelernter, MD, the Foundations Fund Professor of
Psychiatry, professor of genetics and of neuroscience, is
co-leading a study of this population to uncover genetic
alterations that show up more often among traumaexposed vets with PTSD. These data could one day help
estimate individuals’ risk of PTSD based on their genes,
allowing the military to predict that when exposed to
combat, person ‘A’ has, say, a 20 percent risk of developing PTSD while person ‘B’ has only a 5 percent risk.
“Should that affect the role that the person is placed
in by the military? Is this something we should tell the
person, so that he or she can make a decision about the
kind of stresses he’s willing to be exposed to?” Gelernter
asks. “Those are open questions, but they’re things we’ll
be facing—if not in the next year, in the next five years.”
Further, he says, “the genetic information will also aid
us in understanding the factors that underlie PTSD on
the one hand and resilience on the other.”
In 1995, then-faculty member Douglas Bremner, MD,
used MRI to discover the first evidence of changes in
brain structure in PTSD—a shrunken hippocampus
in a group of Vietnam War veterans diagnosed with
the disorder. The hippocampus, one of several brain
regions involved in PTSD, helps researchers interpret
loci in the brain as vulnerable trauma or not.
Thanks to a brain-tissue repository, or “brain bank”
of PTSD patients, researchers can now explore the differences between brains from people with PTSD and
those without. The National PTSD Brain Bank is housed
within the National Center for PTSD (NCPTSD) and
the Boston VA Medical Center. The clinical neuroscience division of NCPTSD is based at the VA Connecticut
Healthcare System and the Yale School of Medicine;

it serves as the primary research laboratory for the
National PTSD Brain Bank.
Instead of studying genetic alterations like Gelernter
and his colleagues, Ronald Duman, PhD, the Elizabeth
Mears and House Jameson Professor of Psychiatry and
professor of neuroscience, is examining the activity
of thousands of genes by measuring the mRNA transcripts and proteins those genes express in hotspot
brain regions.
By comparing differences in gene expression in the
brains of patients who were diagnosed during their lives
from PTSD, those who had major depression, and those
who did not receive a psychiatric diagnosis, researchers hope to illuminate where PTSD overlaps with other

would actually target these networks and hub genes,”
Duman says.
Given how few PTSD medications we currently
have, new ones would be no small advance. But as
we map the disorder’s genetic and protein correlates,
we’re likely to learn more about the origins of resilience, too. In its way, resilience is as big a mystery
as the frightening symptoms of PTSD. Why do some
people manage to weather terrible traumas and return
to a healthy baseline?
“Some of the factors that are going to be implicated
in the risk and the vulnerability to PTSD aren’t just
going to be things that help people be less anxious.
They’re also going to be things that help people to

		John Krystal

“PTSD has a lot to
do with the capacity
		 to bounce back.
psychiatric disorders. They also hope to delineate subtypes that might respond differently to treatments.
With the RNA from tissue samples in each of five
regions of 200 brains under study, Duman estimates that
the project is amassing 50 million data points about the
expression levels of 15,000 genes for each brain region
of each subject. To analyze this massive amount of data,
he is collaborating with the bioinformatics group in the
laboratory of Hongyu Zhao, PhD, chair and Ira V. Hiscock
Professor of Biostatistics, professor of genetics, and of
statistics and data science. The project will gradually
untangle networks of genes whose expression is altered
in concert with PTSD, as well as identifying so-called
hub genes that play an outsized role.
“If we understood the gene networks and biochemical changes that are critical for PTSD pathophysiology,
then we could start to think about treatments that

cope and adapt and recover quickly,” Krystal says.
“What we find in relation to the genetics of PTSD is
likely to have implications not only to PTSD, but …
[for] how people face life challenges and grow from
these experiences.”
That too should inform PTSD treatment. When successful, Krystal says, treatment pulls the patient away
from rigid thinking—what some people call the “black
hole” of trauma or depression—giving him or her the
“capacity to approach the world in a much more adaptive and flexible way … learning to see the world as
both dangerous and safe.”
“PTSD,” he adds, “has a lot to do with the capacity to
bounce back.” /yale medicine magazine
Jenny Blair is a frequent contributor to Yale Medicine Magazine.
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Computational
psychiatry: Modeling the
brain’s neural circuitry
Alan Anticevic and John Murray have combined
efforts in order to understand the biology that
underpins the brain’s neural system.
by katherine l. kraines

Imagine a mathematical approach to brain research
that models the mechanistic basis of brain disorders.
Then envision a future in which these models are used
to offer personalized medicine to individuals with
mental health issues. The field of computational psychiatry, a recent subdiscipline that develops and uses
mathematical models of brain function and structure
to explain dysfunction in psychiatric disorders, shows
great promise in meeting those needs.
Within the Department of Psychiatry’s Division
of Neurocognition, Neurocomputation, and Neurogenetics, or N3 Division, two researchers are spearheading research in collaborative computational
psychiatry with the goal of making inferences about
the underlying biology of the brain’s neural system.
Alan Anticevic, PhD, assistant professor of psychiatry and of psychology, and co-director of N3, leads a
clinical neuroimaging laboratory focused on severe
psychiatric illness; and John Murray, PhD ’13, assistant
professor of psychiatry, of neuroscience, and of physics; directs a laboratory that employs computational
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modeling to improve understanding of neural function
and dysfunction in psychiatric disorders.
Before joining forces, both scientists had observed
that many neuroimaging findings, while powerful
in mapping the brain, lack a mechanistic interpretation. Moreover, both saw a critical need to translate
theoretical findings to clinical research in a principled way. “When we first met, it was obvious to us
that a computational-empirical partnership was one
of the few ways we could make a practical impact,”
Anticevic says.
While neuroimaging has come a long way in the last
century, spatial and temporal resolutions are still limited; no human imaging can “see” at the level of individual neurons. “Even when we can experimentally
manipulate brain function with pharmacology, it’s
difficult to make inferences about what’s happening
at the level of neurons,” says Anticevic. “Even a single
unit of fMRI measurement, a voxel, has a rich circuit
landscape made of millions of neurons and kilometers
of axons that we just can’t see.”

To bridge the gap between the seen and unseen,
Murray’s team creates mathematical models of the
brain’s electrochemical activity at the cellular level.
“The models are used to study how perturbations at
the mechanistic level can propagate upward to impact
brain-wide functioning,” Murray says. “Studying
the properties of neurons and synapses allows us
to describe those interactions and activity through
dynamic equations that resemble equations for resistors and capacitors.” Murray’s team then builds models
that incorporate some of the details that simulate neural activity, which are later evaluated with neuroimaging experiments.
“There are many ideas about what may happen at
the neuronal level that drives the cascade of alterations that produce abnormal behavior,” says Anticevic.
“For instance, one prominent hypothesis in psychosis
research is that there may be something ‘off’ in the
way the NMDA receptor is working.”
The NMDA receptor, or NMDAR, is a protein molecule
that lies within almost all brain-cell membranes and
mediates synaptic interactions. Anticevic describes it as
a tiny logical gate with two requirements for excitation:
first, specific molecules must bind to it; second, it must
receive a signal from another cell. When these events
co-occur, the channel opens to allow the flow of positively charged ions, thus changing the cell’s polarization.
“With psychosis, we hypothesize that something goes
quite wrong with this core computational machinery,”
he says. Along with others in the field who are testing this hypothesis, John Krystal, MD ’84, HS ’88, the
Robert L. McNeil, Jr. Professor of Translational Research,
professor of psychiatry and of neuroscience; and chair
of the Department of Psychiatry, observes that giving
healthy individuals low doses of ketamine temporarily
blocks a specific kind of NMDA receptor found in cells
that calm the brain. The result is a transient state with
some of the behavioral symptoms associated with psychosis or schizophrenia.
Anticevic’s research includes administering ketamine in order to study the immediate effects of the
drug that induce psychosis. “We observe pharmacological effects with imaging and behaviorally,” he
says. As the behavioral effects of ketamine occur, specific changes in neural activity across the brain are

captured by fMRI. “With evidence from experiments,
we can put a hypothesis into a mathematical framework that predicts what would happen if we block
NMDA receptors everywhere equally or somewhere
more preferentially,” says Anticevic.
“Only recently has modeling been able to make
experimentally testable predictions for neuroimaging,” Murray says. “Being able to design experiments
and analyses around models is critical because we need
these particular types of data and analyses to iteratively test and refine the models and improve them.”
Computational psychiatry hasn’t yet crossed the
bridge into clinical practice. However, the researchers
hope that their work will reveal the diverse mechanisms of brain disorders and provide models that
can be used to make predictions at the level of the
individual patient. These models in turn will minimize clinical guesswork regarding causes and treatments. The National Institute of Mental Health (NIMH)
actively supports research in the field of computational neuroscience.
Anticevic noted that collaborative research within
the N3 framework offers a multidisciplinary approach
that attracts researchers from physics, mathematics,
computer science, computer engineering, neuroscience, psychiatry, clinical psychology, and cognitive
neuroscience. “The problem doesn’t care about your
background,” says Anticevic. “There isn’t any one skill
set that can tackle this challenge. It’s bigger than any
one lab.” /yale medicine magazine
Katherine L. Kraines is a frequent contributor to Yale Medicine
Magazine.
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Why concussions
hurt some people
more than others
by sonya collins
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The National Football League’s 2017–2018 season
brought a stunning first-ever Super Bowl win for the
Philadelphia Eagles—and an equally stunning number
of head injuries. The 281 reported concussions represent a 13.5 percent increase in such injuries over the
previous season and an overall five-year high. While
the League’s 47 rule changes since 2002 have done little
to reduce concussion rates, the steady upswing keeps
the issue on the public health radar.
Sports-related concussions are not limited to professionals, nor are their residual effects. The Centers for
Disease Control and Prevention estimates that some
135,000 children between the ages of 5 and 18 are
treated in emergency rooms for sports-related concussions every year. The National Collegiate Athletic
Association sees more than 10,000 of these injuries
each year. In all of these groups—youth, collegiate, and
professional athletes—a link between concussion and
depression is apparent. What’s more difficult to tease
out is the precise relationship between the two.
“Most athletes after a concussion actually recover
quite quickly and don’t have these residual symptoms,” says Franklin Brown, PhD, assistant professor of neurology and chief of the Division of Yale
Medicine Neuropsychology. “There’s been multiple
areas of research determining why others don’t
recover so quickly.”
One such study, published in the journal Clinical
Neuropsychologist in March 2013, drew on previous
research to conclude that 15 to 30 percent of people
who suffer a mild traumatic brain injury report lingering symptoms.
An estimated 18 percent of adults develop new-onset
depression after a concussion. But definitively “new”
cases of depression can be tough to identify after concussion. Depression can often appear to be the result of a
head injury when in fact it was only exacerbated by the
injury. “The vast majority of people who don’t recover
quickly usually have preexisting mental health issues,”
says Brown. Research shows that pre-existing depressive and pre-existing concussive symptoms are both
major predictors of post-concussion depression.
Concussive symptoms don’t always mean a history
of concussion. Many people in the general population
experience such common concussion-like symptoms

as headache, fatigue, and dizziness from time to time.
The same is true of depression. Often, people live with
these symptoms and never report them. A concussion can draw patients’ and doctors’ attention to these
symptoms for the first time, though they may have
been present before.
A small study illustrated the prevalence of “postconcussion-like” symptoms and their overlap with
depression in a population with no history of concussion.
The healthy study participants completed standard postconcussive and depressive symptom inventories. At least
one of the concussive symptoms had been expressed by
36 percent of the respondents in the last two weeks. Up
to 15 percent had experienced the more severe symptoms.
What’s more, the researchers found significant overlap
between those who reported concussion-like symptoms and those who reported depressive symptoms. The
research didn’t establish a causal relationship, but rather
underscored the correlation more vigorously.
While researchers don’t entirely understand this
interplay, they have recognized it for some time.
“Neurological and psychiatric symptoms and diagnoses
very commonly run together,” says Deena Kuruvilla,
MD, assistant professor of neurology. “For example,
depression and anxiety are some of the biggest risk factors for developing chronic migraine.”
She adds, emphasizing their physiological link,
“Antidepressants can be helpful for treating migraine,
depression, and anxiety.”
A recent review in Neural Regeneration Research
explores a possible mechanism for the overlap, inflammation. The study found a pro-inflammatory state
present in the brain in both depression and traumatic
brain injury. Each condition can exacerbate the other.
“The pro-inflammatory state can persist for months to
years after injury,” says Kuruvilla.
Regardless of whether the neurological or the psychiatric symptoms come first, these issues can escalate
and multiply if unchecked. “Depression, mood change,
headache—these are the things we can treat after
concussion,” says Kuruvilla. “If these symptoms go
untreated, the patient’s quality of life can deteriorate.”
/yale medicine magazine
Sonya Collins is a frequent contributor to Yale Medicine Magazine.

Spring 2019

31

When researchers
listen to people who
hear voices
The line between mental illness and genius has long
been known to be razor-thin. Yale researchers stumbled upon evidence of this fragile boundary while
researching auditory hallucinations in schizophrenia.
by christopher hoffman

The last thing you’d expect Yale School of Medicine
brain researchers to do is hang around with psychics,
let alone enlist them in their research. But that’s exactly
what Albert Powers, MD, PhD, HS ’16, assistant professor of psychiatry, and Philip Corlett, PhD, FW ’10, associate professor of psychiatry, have been doing since 2014.
Even more surprising, the unusual partnership has
produced insights that could one day revolutionize the
diagnosis and treatment of schizophrenia.
“The irony is not lost on me,” says Corlett, with a
broad grin.
Corlett and Powers’ unlikely journey into the
world of psychics began when they resolved to better understand the phenomenon of schizophrenic
patients who experience auditory hallucinations, colloquially known as “hearing voices.” The researchers
wanted to study people who’d had similar experiences
but didn’t seek or appear to need treatment. Thanks
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to recent research, the pair knew that such people are
surprisingly common. As much as 8 percent of the
population reports experiencing auditory hallucinations on a regular basis (13 percent hear them at least
occasionally), compared to just 1 percent who are
diagnosed with schizophrenia. Where to find them?
The pair considered charismatic Christians, practitioners of Santeria, practitioners of voodoo, crystal healers, and self-proclaimed druids. None panned out.
One day while riding the bus home, Corlett noticed
the large number of storefronts offering psychic readings. Perhaps people who go to psychics would fit the
bill, he thought. Powers and Corlett reached out to
the president of the American Association of Psychics’
Connecticut chapter, who informed them they were
looking for clairaudients—psychics who use voices
in their heads to give readings and, the clairaudients
believe, communicate with the dead.

Powers started going to association meetings and
psychic fairs with another researcher, Adina Bianchi, to
talk with clairaudients, Corlett says. Almost immediately, they believed that they had found their study subjects. To confirm their hunch, the researchers asked the
psychics to undergo a battery of tests, including brain
scans and an extensive survey that included questions
designed to unmask fakers. The psychics passed with
flying colors, leading Corlett and Powers to conclude
that they hear voices much like schizophrenic patients
do, but with key differences—the voices are friendly,
they can be controlled, and hearers consider them a gift
instead of a burden.
The clairaudients have proven enthusiastic participants, Corlett adds. “One of the wonderful things
about working with this group is they are delighted
that we are taking them seriously,” he says. “We said,
‘We have no interest in debunking. We agree to disagree [on the cause of the voices], but we believe you
are having real experiences.’”
One volunteer for the study was Brittany Quagan,
who says she first heard voices as a young girl. At 15
or 16, the voices became a serious problem, leading
to years of therapy and drug treatment. Her breakthrough came at 21, when a work colleague who was a
psychic suggested the voices were evidence of psychic
powers, not mental illness. Quagan says she became
convinced that her friend was right after Quagan
recounted facts about a co-worker’s recently deceased
relative to the surprised co-worker.
After her revelation, Quagan says that she quickly
gained control of the voices—one is a man, the other a
woman with a British accent. She stopped taking medication and turned her life around. She quit her job and
began giving psychic readings full time.
“I call them guides,” she says of her voices. “It’s
almost like calling a friend, ‘Hey, come here!’ That’s
how I connect to them.”
Powers and Corlett’s study subjected the psychics,
people diagnosed with schizophrenia, and non-voicehearers to a simple Pavlovian test devised at Yale in the
late 19th century. A light and a sound are paired, with
the sound becoming steadily fainter and eventually
ceasing. The brain, however, continues to perceive the
sound even when it’s not there. Researchers can use

the test to induce a minor hallucination—hearing a
sound when there is none—in anyone.
The test results were startling, the patients with
psychosis and the psychics were five times more likely
than non-voice-hearers to perceive a sound when
there was none. Brain scans done during the testing
showed that the same parts of the two groups’ brains
were activated when they perceived sounds that were
not there.
The findings, which Corlett and Powers published
in the August 11, 2017, issue of Science magazine, have
huge potential for the diagnosis and treatment of
schizophrenia. Treatments could eventually include
devices to short-circuit brain activity that causes hallucinations and behavioral strategies to forestall psychosis, the researchers say.
“I’d say we’ve made a massive leap forward in terms
of conceptual understanding, and what we’re trying to
do next is turn that into something useful for patients,”
Corlett says.
The psychics will remain vital partners in their
ongoing work, both men say. Powers has gone a step
further, he has hired voice hearer and test subject
Quagan, who is in the final stages of obtaining her
therapist’s license, as his new lab manager. While
Quagan remains convinced that her voices and psychic
powers are real, she has come to accept that they may
have a neurological component.
“Whether what we [psychics] do is real or not, I’m
not going to argue,” Quagan says. “We all have different beliefs. But the underlying narrative for all of us is
that we found a way to cope. We found a way to work
with our experiences. Because of that, we were able to
move away from what could have been a downward
spiral.” /yale medicine magazine
Christopher Hoffman is a frequent contributor to Yale Medicine
Magazine.
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Speeding treatment
blunts the worst of
schizophrenia
An interdisciplinary program called Specialized
Treatment Early in Psychosis, founded by Vinod Srihari,
MD, is helping speed treatment of schizophrenia.
How quickly the condition is diagnosed and treated
can determine a patient’s odds of living a relatively
normal, albeit medicated, life.
by john curtis

A few years ago, a young man and his family came to
the Connecticut Mental Health Center (CMHC) to seek
help. The college student was having troubles that
seemed to go beyond the run-of-the-mill concerns of a
young adult.
“It was clear to us that the reason he could not keep
up in school was not depression or anxiety, but an
emerging psychotic disorder,” says Vinod Srihari, MD,
HS ’03, FW ’05, associate professor of psychiatry.
The young man was hearing voices, a classic sign of
schizophrenia. The voices commented on whatever he
was doing in the moment, disparaged his appearance,
and ordered him to do things he didn’t want to do.
Srihari’s first step was to make the patient
feel comfortable with treatment, which included

psychotherapy and antipsychotic medication to quell
the voices. He also helped the young man’s family
understand what was happening.
Between four and five months passed from the onset
of symptoms to treatment. This may seem like a long
time, but Srihari says average delays in typical care settings can be much longer. Though this pathway to treatment was relatively short, Srihari believes this period,
called the duration of untreated psychosis (DUP), is still
too long. This is an ongoing area of research, but studies
have linked early treatment to better outcomes.
For the past four years, Srihari has led MindMap, a
study funded by the National Institutes of Health, to
test that theory. Previously, he launched an interdisciplinary program called Specialized Treatment Early in
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Speeding treatment blunts the worst of schizophrenia

		Vinod Srihari

“Schizophrenia spectrum disorders
denote a very diverse group of
			 what are probably many different
		 diseases with distinct causes;
nevertheless, this is still a meaningful
			 construct that can tell us a lot about
the kinds of experiences people are
			 undergoing, the challenges they
		 are likely to have, and the treatments
				that will be helpful.

Psychosis (STEP), which demonstrated that a specialty
team-based model of care resulted in better outcomes.
Srihari launched STEP in 2006, after securing
approval from the state of Connecticut to provide care to
all youth with new-onset psychosis at CMHC, regardless
of insurance coverage. The center was already open to
those on Medicaid or without insurance, and STEP was
permitted to care for those with various commercial
insurance plans. STEP reflects a collaboration between
the Connecticut Department of Mental Health and
Addiction Services and the Department of Psychiatry.
“We start a treatment plan that is focused on helping
them comply with medication and stabilizing their
symptoms, and we start work on getting them back to
work or school,” Srihari says.
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Each person has at least a one-in-100 chance of
developing schizophrenia in their lifetime. Without
early and effective treatment, the symptoms can
render them unable to work, study, or maintain
friendships. “This is a disorder that punches well
above its weight in terms of burden, even though
it is not as common as other mental illnesses,”
Srihari says. Its cause remains a mystery, although
researchers have identified genetic and environmental risk factors.
First termed schizophrenia by early 20th-century
Swiss psychiatrist Eugen Bleuler, it is now considered
a group of disorders that share signs (observable by
others) and symptoms (subjective experiences) that
include hallucinations, delusions, and the inability to

take pleasure in everyday life, trouble focusing, and
loss of working memory.
“Schizophrenia spectrum disorders denote a very
diverse group of what are probably many different diseases with distinct causes,” Srihari says. “Nevertheless,
this is still a meaningful construct that can tell us a lot
about the kinds of experiences people are undergoing,
the challenges they are likely to have, and the treatments that will be helpful.”
Because schizophrenia strikes when people are
young, usually in adolescence or early adulthood, it
can be hard to distinguish the symptoms from gardenvariety teenage angst.
“They may withdraw socially from their friends.
They might struggle in school,” Srihari says. “It can
look like depression or anxiety, which they may be
experiencing, but psychotic symptoms can be less evident, especially when individuals may feel less comfortable talking about unusual subjective changes.”
Getting patients to treatment can be a challenge.
Some may not want to admit that they have a mental
illness, or fear that they’ll be locked up. That period
between diagnosis and treatment—the DUP—is crucial,
Srihari says, because that’s when patients are at the
highest risk of aggression, suicide, losing jobs, losing
relationships, and dropping out of college.
“There is a subjective journey within which the young
person and the family come to figure out this is an illness
and professional assistance is necessary,” Srihari says.
“It can begin in a jarring manner, with a police officer
finding you on the street and taking you to the emergency room or to jail. However, if you’re in a state like
Connecticut, you may have a jail diversion officer who
says you don’t belong in jail, you need treatment.”
To shorten the pathway to treatment, Srihari and
colleagues launched the MindMap study in 2015.
MindMap, which covers New Haven and nine neighboring towns, is based on Norwegian research findings
that showed earlier access to treatment resulted in better outcomes. MindMap has three prongs: first, a social
media campaign raises awareness of psychosis among
young people, their friends and family, clinicians, and
others; second, the program reaches out to community stakeholders who are in contact with adolescents
and young adults—such as mental health providers,

primary care providers, clergy, college counselors,
police, and community groups; third, MindMap tracks
how many phone calls come into the program and how
many calls transpire between first contact and care.
There’s no difference in the care provided—the variable
is getting patients into treatment quickly.
A control program, which offers treatment but
no campaign to reduce waiting time, is underway in
Boston. The New Haven program ended in February
2019, but interim results are promising, Srihari says.
Two and a half years in, the median delay from onset
to prescription of an antipsychotic dropped from about
150 days to 40 days.
“It remains to be seen—if we get our act together and
provide early intervention across the U.S.—whether it
will change the face of chronic schizophrenia,” Srihari
says. “The real gains will be realized over a 20-, 30-,
40-year lifespan, when our hope is that people are less
likely to be on disability and will retain their employment, retain their insurance, and retain their families.”
As a success story, Srihari points to the young man
who came to STEP a few years ago. After two years, he
“graduated” out of STEP and now receives treatment
from a community physician. He will need treatment,
including antipsychotic medication and psychotherapy,
for the rest of his life. Yet his symptoms have receded,
and he has a job that involves helping others get rehabilitative services.
“For us, this is an arc that has been fulfilling,”
Srihari says. “He has a job, he has commercial health
insurance—he is a contributing member of society and
does not need intensive or specialized treatment with
us anymore.” /yale medicine magazine
John Curtis is a frequent contributor to Yale Medicine Magazine.
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Tackling addiction with
treatment and predictive
outcomes modeling
Researchers provide insights into the biological profiles the underlying risk of substance use relapse,
while treatment methods offer patients new options.
by adrian bonenberger

From the predictive to the prescriptive, advances in the
science of addiction treatment are bringing us closer
to delivering on the long-implicit promise that functional recovery from substance use disorders is possible. Mapping neural profiles to identify individuals
at risk of addiction to certain drugs, investigating the
underlying causes of relapse, and expanding the reach
of successful behavior modification techniques all give
patients with substance use disorders cause for hope.
your own neurological map
Researchers in the lab of Kathleen Carroll, PhD, the
Albert E. Kent Professor of Psychiatry, combined
machine learning and neuroimaging to build a brainbehavior model that predicted cocaine abstinence
among a group of 53 people who were entering treatment for cocaine use. The researchers applied this
model to neuroimaging data from a group of 45 individuals who were also entering treatment, and found
their prediction of who would abstain from cocaine
during treatment to be 70 percent accurate. Led by
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Sarah Yip, PhD, FW ’15, assistant professor of psychiatry, and in the Yale Child Study Center; in collaboration with Dustin Scheinost, PhD ’13, FW ’15, assistant
professor of radiology and biomedical imaging, and in
the Yale Child Study Center, the team laid the groundwork for evaluating mechanisms that could guide the
treatment of patients.
“We don’t have a good predictor of who will benefit
from a course of treatment,” says Yip, “Using these
data analysis approaches, we hope to one day be able to
tailor treatment to individuals.”
Yip’s research points in the direction of a personalized neural map that may one day save patients
valuable time, money, and resources—not to mention
heartbreak. Published online in the American Journal
of Psychiatry on January 4, 2019, the prediction of
cocaine abstinence based on the connectome—a complete map of neural connections in the brain—also
provides insight into the neurobiology of recovery,
which may speed the development of novel interventions to further improve outcomes.

rerouting the road to relapse
While researchers like Yip develop predictive tools to aid in
addiction treatment, other clinicians and researchers are
focusing on another problem area—the threat of relapse
once a patient successfully completes a course of treatment.
“Our targets are channels that influence dopamine activity
in the brain,” says Nii Addy, PhD ’07, associate professor of psychiatry and of cellular and molecular physiology. “Certain cues can trigger drug relapse—think about
the smoker who’s attempting to quit, and then returns
to a bar to socialize with friends, only to find themselves
smoking again. We’re using rodent models to understand
what happens in the brain that allows cues to bring about
that relapse. A great deal of research has shown that brain
dopamine levels increase in the presence of drug cues.
So channels that decrease brain dopamine concentrations
could be potential therapeutic targets for drug relapse.”
Addy’s project, funded in part by a grant from the
National Institutes of Health, focuses on L-type calcium
channels in cells, which are channels that allow calcium
to enter the cells. These channels affect how dopamine
(the neurotransmitter most responsible for stimulating
the reward system within the brain) acts neurologically.
At present, scientists mostly understand the roles dopamine plays in motivating reward, regulating mood, and
fostering learning. Figuring out when and how to regulate dopamine could allow scientists to develop treatments that short-circuit addictive behavior as well as
lower the risk of relapse.
Addy’s interest in the neurological makeup of
substance use disorder was sparked when he was an
undergraduate at Duke University. He worked in a lab
where researchers studied how nicotine could reverse
the cognitive deficits associated with schizophrenia
and antipsychotic medications.
One discovery that surprised Addy during his most
recent research is that blocking the calcium channel
decreased the frequency of relapse among subjects but
increased dopamine levels. “That was the opposite of
what we expected, given current understanding of
how dopamine operates,” Addy says.
reprogramming neural pathways
Carroll has spent nearly 30 years developing a program called Computer Based Training for Cognitive

Behavioral Therapy, or CBT4CBT. The program takes
a model proven to facilitate positive changes in a person’s actions—cognitive behavioral therapy—and offers
it online to patients with a substance use disorder.
Developed and tested with support from the National
Institute on Drug Abuse and the National Institute on
Alcohol Abuse and Alcoholism, CBT4CBT makes a standardized, effective form of treatment available to people
wherever and whenever they need it; it is particularly
promising in reaching underserved populations.
CBT4CBT started when Carroll saw the potential for
technology-assisted treatment in the early 2000s.
“My daughter loved learning to read while sitting on my
lap using the Clifford the Big Red Dog program on the
Public Broadcasting Service website,” says Carroll.
“I realized that CBT could be taught and practiced
remotely using those new multimedia tools. We think
that by demonstrating cognitive and behavioral selfcontrol skills and strategies in an engaging, fun way—for
example, by including a series of videos that show people
using the skills in real-world challenging situations—
we’ve developed a very powerful tool. Here we are nearly
20 years later, and the technological opportunities for
treatment have far exceeded early expectations.”
Asked how CBT4CBT compares to other forms of
treatment for substance abuse disorders, Carroll is
optimistic. “We spend billions in the U.S. on treatments that haven’t been proven or even shown not to
work, like detoxifying people without follow-up,” she
says. “We have tested CBT4CBT extensively in over
seven randomized clinical trials, and have shown that
it can have better outcomes than standard outpatient
treatment while costing a lot less. Plus, patients really
like it, which is the bottom line.”
There is still much to learn about how bodies respond
to treatment for substance use disorders. Yip, Carroll,
and Addy are all bringing medical science and the clinical application of that science closer to the day when
substance use disorder is seen as a treatable chronic disorder that can be managed, enabling people to resume
happy, productive lives. /yale medicine magazine
Adrian Bonenberger is the editor of Yale Medicine Magazine.
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“The Crack-Up,” by Corporal Wayne Seese, uses an
unusual palette to depict
a public moment of
private anguish amid the
Pacific campaign during
World War II.

		 The Clements
Collard Fry Collection
		 Clements Collard Fry slowly amassed an astonishing
collection of prints and drawings that he
			 bequeathed to the university after his death
		

By Adrian Bonenberger
He never thought of him-

Hygiene in the Department

a book on the subject—

said Wheeler. “But as

self as a collector. He just

of University Health at Yale

Five Hundred Years of

Mitchell’s works became

bought pieces he enjoyed

after 1937, made an effort

Medicine in Art—which

harder to find and more

and could share with oth-

to acquire it.

was published in 2001.

ers who might appreciate
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By the end of Fry’s life,

medical history, art, or

he’d accumulated over

“Clements Collard Fry

expensive, Fry turned to
rare medical prints. Over

developed an interest in

time that interest developed in sophistication,

representations of illness.

2,000 prints, covering five

collecting fairly early in

Humorous, serious,

centuries and the work of

his life, first focusing on

and what you see in the

valuable, or sad: if a draw-

hundreds of artists. Susan

manuscripts and editions

collection today is the cul-

ing or print caught his

Wheeler, the Medical

of Silas Weir Mitchell, a

mination of a lifetime of
collecting medical art.”

eye, Clements Collard Fry

Historical Library’s cura-

pioneer in the treatment

(1892–1955), MD, head

tor of prints and drawings

of nervous disorders and a

World War II seemed

of the Division of Mental

and historical medical

prominent literary figure,”

to be a turning point for

posters, knows more

Fry as a collector. While

about Fry’s collection

working in Washington,

than anyone else alive,

D.C., with the National

having spent a great deal

Research Council, Fry

of time with it. She wrote

became immersed in the

collection of prints and
drawings at the National
Gallery of Art. An unusual
drawing from this time,
“The Crack-Up,” portrays
a U.S. soldier who has a

assistant to the ship’s

breakdown during the

steward of a merchant

Pacific campaign. Taken

marine vessel] at the time.

from an event that the

He stepped out of his tent

artist (Corporal Wayne

and in the darkness

Seese, U.S. Army) wit-

ran into a tree and went

nessed, “The Crack-Up”

to pieces. Rumor was that

was shown as part of a

he had just received a

late 1945 exhibition U.S.

letter that both his sister

Marine Combat Art, that

and father were killed

included 130 drawings

in an accident, but I

by 22 Marines. When Fry

don’t know.

contacted the artist to

ing extent, World War II

drawings, Seese replied:

was viewed through

The “Crack-Up” came

drawings made by combat artists,” said Wheeler.

the island of New Britain,

She explained that iconic

after the Cape Gloucester

photographs captured the

campaign … One night as

public’s attention, but that

we sat in our … tent, bed-

handmade illustrations

lam broke out across the

of events still provided

street at sick bay. Rushing

civilians back home with

over there, we came upon

powerful visualizations of

the scene I have put down

the war.

on paper.
Yelling, sobbing, and

The school continues to
acquire prints and draw-

talking, the kid was held

ings through gifts and

down by a couple of his

endowments, adding to

buddies while the doctor

the collection’s diversity.

prepared a sedative. The

They reflect Fry’s aesthetic

scene was pretty weird

and professional interests.

with hundreds of fel-

“The items we have

lows drawn by morbid

acquired over the past

curiosity standing in

50 years build on what

the darkness …

Dr. Fry’s collection was,”

The kid was a rugged-
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“Perhaps to a surpris-

learn the story behind the

from a scene I witnessed on

LEFT Clements Collard
Fry’s collection included
many period pieces describing scenes or profiles
(often satirical in nature)
that illuminated a disease
or disorder. Relatively
few, however, described
maladies contemporary
physicians would diagnose
as mental illness.

said Wheeler, “and help

looking boy about

bring it into the present.

nineteen or twenty, a

Dr. Fry used to show these

messman [entry-level

prints to his colleagues and

ABOVE One of the prints

Fry collected on the subject
of madness.

LEFT The collection has
pieces of historical significance, such as those dealing
with 18th- or 19th-century
American history.

students—he liked people’s
seeing them and delighting in their stories. We do
what we can to continue
that legacy.”
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A well-balanced life:
Sharon Weinstein’s
long career of service
sharon weinstein, md ’78, knew that she wanted to
be a psychiatrist at the age of 10. She read Nancy Drew
and The Hardy Boys, but also Scientific American and
Freud’s books on dreams. She idolized pioneering
scientists like Marie Curie, wrote to Jonas Salk, and
was thrilled when the discoverer of the first polio vaccine replied. “From early childhood, I have always been
interested in how people live their lives,” Weinstein
said, “learning how they face challenges and overcome
adversity to realize their dreams.”
Curiosity served her well. The
Massachusetts Psychiatric Society
recently honored her with the
2018 Award for Outstanding
Psychiatrist in Education for her
multifaceted teaching and program development in child and
adolescent psychiatry.
Weinstein expresses gratitude
to those who gave her roots, her
family and mentors. Growing
up in Hartford, Conn., as the
oldest of five, hers was a childhood of stories. “I used to listen to stories about my Jewish
grandparents immigrating to
the U.S. from Poland to escape

42 ymm.yale.edu

pogroms and find freedom,”
she recalled. “They came here
with little, starting with my
grandfather having a pushcart,
to establishing a grocery store
where people would congregate
to ask his advice and share their
stories. I listened to family stories of courage and resilience, of
my dad’s bravery at Normandy
on D-Day, and about my mom’s
dedication to her family.”

Service and education were
woven into the family’s culture.
“In Europe, my grandmothers
were denied educational opportunities,” Weinstein said. “We
understood what a privilege
education was.” Her parents
ensured their children engaged
with a spectrum of subjects, in
school as well as at home and
in the community. Weinstein
thrived with the multidisciplinary concept—it would in fact
become a pillar of her professional focus. “I was fascinated
by connections between mind,
brain, body, and society,” she
said. “I think that was fostered
by a range of life events in a
large, multigenerational family.”
In many ways, Weinstein is a
product of her environment. Her
psychiatry practice exists at the
intersection of science and art
and of the personal and environmental, where culture, spirituality, and medicine meet. These
elements were embedded in her
heritage and ignited by her coming of age against the backdrop
of a shifting world. In the 1960s,
Weinstein attended a “large public high school marked by cultural, ethnic, and socioeconomic
diversity,” and she began college
in an era of political upheaval
and social change, particularly
for women. Some regarded
Harvard’s introduction of coeducational housing her sophomore
year there as an unwelcome
break with tradition. Women
were gaining admission to medical schools in greater numbers,
but at Yale, Weinstein remembers

E R I K JAC O B S P H OTO

some female classmates being
told they were “taking the place
that a man could have, that they
would have children and stop
practicing medicine.”
Weinstein challenged
biases through evidence-based
research—her approach since her
first science fair project when she
was 12. In college, she disputed
the belief that women should
not hold key political positions
because of “raging hormonal
influences” by writing a thesis
examining emotions throughout
the menstrual cycle. In medical
school, her thesis centered on
gender differences in depression.
“It was an exciting time,” she said.
“The whole field of gender and
female development was being
studied, researched, and radically revised to the good.”
Weinstein volunteered at
pregnancy counseling services
in Boston and often accompanied women seeking legal abortions to clinics in New York,
sometimes crossing picket lines.
“I grew up seeing how important
it is for a woman’s dignity and
self-actualization to have the
right to make choices about her
own body,” she said.
Weinstein also recognized the
connections between environment, biology, psychology, and
development, and deepened her
appreciation of knowing and
treating the “whole person” at
Yale School of Medicine. “Yale
was renowned for excellence and
an innovative, far-reaching curriculum, especially in psychiatry,”
she said. “Outstanding faculty

Weinstein is grateful
for the foundation and
stability her family
provided, and she has
striven to build the
same for her own son,
now 23. “It’s such a gift
to see the excitement
in children when they
accomplish their goals,”
she said.

taught us a humanistic, compassionate approach to the doctorpatient relationship.”
Weinstein brought the multidisciplinary philosophy to her
adult residency and child and
adolescent residency at McLean
Hospital in Belmont, Mass., and
to the Boston Psychoanalytic
Society and Institute (BPSI). She
ultimately focused on work with
children, adolescents, adults,
and families, both in her private
practice in Lexington, Mass.,
and in paying forward her family’s educational legacy through
teaching at McLean and Harvard
Medical School.
The Massachusetts Psychiatric
Society award is the latest in
Weinstein’s encyclopedicrésumé, which includes honors
for leadership in clinical work,

education, and advocacy. She is a
Distinguished Life Fellow of the
American Psychiatric Association
and the American Academy of
Child and Adolescent Psychiatry;
received a Lifetime Achievement
Award from the New England
Council of Child and Adolescent
Psychiatry (NECCAP); and has
served several terms as NECCAP
president. Over 30 years, she has
organized 170 psychiatric conferences and taught thousands of
Harvard Medical School students
and psychiatric residents.
Looking forward, Weinstein
is concerned about a critical
shortage of child and adolescent
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online exclusive

PA Online students visit
Yale twice during their
didactic year to get
“hands-on” experience
with professors and
interact with each other.
Yale Medicine Magazine
popped in to see how a
recent visit went, and
what the students
learned from their immersion exercise.
For more on their talk,
visit ymm.yale.edu/
immersion

led Ayana Jordan, MD, PhD, to
an epiphany as she sought a
better way to help poor people
struggling with drug addiction.
Though it happened in church,
her epiphany was not religious
psychiatrists. “Nearly one in
in nature. Jordan realized that
five U.S. children has a mental,
the influence and support of
emotional, or behavioral disthe African Methodist Episcopal
order within a given year, and
Zion Church could provide
only about 20 percent receive
the transformative experience
care from a specialized mental
people needed when they didn’t
health care provider,” she said.
have much trust in health care.
“We need more pediatric psyThrough her positions as assischiatrists to meet these needs.
tant professor of psychiatry and
It’s a dynamic and rewarding
director of the Yale Global Mental
field. With significant advances
Health Program, she was able to
in research and treatments,
draw on colleagues and church
psychiatrists can partner with
leaders to break new ground in
families and colleagues to advocate, help children build on their addiction interventions.
Raised in Pittsburgh, Jordan
strengths, and create solid founbegan her award-studded
dations for the future.”
academic life with an underWeinstein finds her work
graduate degree in biology from
hopeful and embraces the
Hampton University in Virginia,
optimism of change and posa school steeped in Black hissibilities. “Much of the power of
tory and culture with a progresintervention, through educasive mandate. She embarked on
tion, connection, social action,
an MS in pathology at Albert
and multimodal evidence-based
Einstein College of Medicine
treatments is in being able to
rewrite your narrative,” she said. of Yeshiva University in the
Bronx, then stayed on for an
“You can see your past through
MD/PhD program.
a different lens and rewrite your
Completing the combined
narrative for the future, knowdegree program is a rare accoming that the end of the story has
plishment for any student. The
not yet been written.”
number of Black women who
As with her family, it all
achieve it is miniscule. “I planned
comes back to stories.
to go into internal medicine and
—Lauren Johnson
infectious disease,” she said since
she earned her PhD in immunopathology. But during the program, she did clinical work in
A study in innovation:
psychiatry in the South Bronx.
Reinventing substance
use disorder intervention “I had never seen that level of
The fields of education and psychiatry value researchers who
are willing to combine fresh ideas
with traditional solutions. That
kind of open-minded approach

»
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poverty in the U.S. It really struck
me,” she said. This experience
changed the trajectory of her
career. “I realized I could make a
bigger impact in the underserved
and marginalized communities.
There is such a big mistrust in
those communities around mental health and mental illness.”
The existing interventions weren’t
working, and she felt compelled
to find a solution.
“To improve outcomes for
marginalized populations, we
need to involve them from
research to clinical interaction—
every step of the way,” Jordan
explained. This kind of community-based participatory
research wasn’t an option in most
residency programs. At Yale, she
found an environment that supported her vision to integrate the
cultural and religious aspects of
people’s lives while also addressing the disparities that can hold
them back from improved mental
health. Jordan also discovered a
community in need: According
to the National Institutes of
Health, Connecticut is among the
top 10 states for overdose deaths
from opioid abuse. She arrived in
New Haven in 2011, as the rate of
opioid deaths in the state started
to climb dramatically.
During her residency, she
served as program-wide chief
resident in psychiatry; completed a fellowship in addiction
psychiatry; amassed a dozen
awards, including the Resident
Recognition Award from the
American Psychiatric Association
(APA); and found an innovative

approach to community intervention. When Jordan arrived
in New Haven, one of her top
personal priorities was to find
a Black church. She joined
Varick Memorial AME Zion
Church, which has a long tradition of participation in studies
at Yale. Knowing that the Black
church had been instrumental
in changing how people thought
about HIV, Jordan realized
the church community could
help with another stigmatized
epidemic: mental illness, specifically substance use disorder.
She approached the pastors to
propose a pilot of a communitybased treatment program within
the church.
While it may sound a bit like
12-step meetings held in church
halls, which Jordan acknowledges
can help many people, this program is quite different. “Here we
are focused on being Black, being
spiritual, [and] the church itself
is involved in the care,” she said.
“It’s not about bringing people to
Jesus, and participants are often
not part of the congregation,” she
explained. “It’s about a safe place
where people can get help.” The
pilot program was held in Dixwell
Avenue Congregational United
Church of Christ. It included
evidence-based computerized
cognitive behavioral therapy, and
received an overwhelmingly positive response.
At the same time, Jordan
hoped to bring a faith-based initiative to members of the Black
community with opioid use disorders throughout the state. That

led to a collaboration with Chyrell
Bellamy, MSW, PhD, associate
professor of psychiatry, on a program called Imani Breakthrough
(imani means “faith” in Swahili).
With input from peer facilitators
and church leaders, they added
the traditions and values of the
church to a curriculum based
on the Citizens-Community
Enhancement Project, an intervention shown to be effective
for people with serious mental
illness that includes substance
use disorders.
The foundation of Imani
Breakthrough is the 5Rs model
from the Citizens’ Project, created by Michael Rowe, PhD,
professor of psychiatry, and his
colleagues. The model emphasizes the “rights, responsibilities,
roles, resources, and relationships” of community members.
Imani Breakthrough also incorporated a support system that
encompasses spiritual, social,
financial, emotional, environmental, intellectual, physical
and occupational aspects of
life—the “Eight Dimensions of
Wellness,” as outlined by the
Substance Abuse and Mental
Health Services Administration
of the U.S. Department of Health
and Human Services.
Imani Breakthrough aims to
help people gain independence
without relying on perennial
attendance at meetings. The program involves 12 two-hour weekly
meetings and refers patients to
medication-assisted treatment and
wellness counseling when appropriate. It also includes one-on-one

support to address such factors
that might compromise success
as issues with housing, jobs,
and transportation.
When the program launched,
hundreds of people came. The
success led to further funding for
another year. Jordan and Bellamy
are now expanding the program
by designing a version for the
Latinx community. “The next
challenge is preparing a large
randomized controlled trial to
determine if partnering with the
faith organizations works better
than traditional substance use
clinics,” Jordan said.
While Jordan has won many
awards and accolades, one of
her favorites was bestowed at
Yale’s commencement last June:
the Faculty Diversity Award.
“I wanted to recruit residents and
faculty that are reflective of the
population, to make sure all kinds
of people are at the table—race,
gender, point of view, where we
trained, and more. You can’t be an
excellent physician unless you are
aware of the cultural identity that
patients bring into the room and
take that into consideration in the
treatment plan. Yale psychiatry
is starting to reap the rewards of
being focused on inclusion.”
Jordan said she hopes to help
everyone find a path to recovery,
regardless of past failures. “My
ultimate dream is to open up a
substance abuse wellness center
that not only deals with the biological aspects of substance use,
but equally addresses the social
determinants of health,” she said.
—Elena Rover
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question and answer

			 The biochemical
basis of human mood
DURING HIS FIRST SUMMER IN COLLEGE, John Krystal,

MD ’84, HS ’88, chair of Yale’s psychiatry department,
traveled from the University of Chicago to help patients at

of activity in the sphere
of public mental health.
First, the numbers of
people diagnosed with

a methadone-dispensing addiction clinic in Boston. In a

anxiety and depression

biochemistry class that autumn, he learned about the dis-

rate of serious conse-

covery that the body makes opioid-like molecules called

treated mental illness,

endorphins that act via the same receptors in the brain as

like disability and sui-

drugs like heroin and methadone. An idea clicked. “That

we have a very serious

suggested to me that the problem of addiction might have a
scientific underpinning,” Krystal, the Robert L. McNeil, Jr.

are going up. Second, the
quences of inadequately

cide, are going up. Third,
shortage of psychiatrists
and psychologists. We’ve
tolerated this shortage

Professor of Translational Research, professor of psychia-

because society has tra-

try, and of neuroscience, said, “and that the complexity

illness as something that

and unpredictability of clinical psychiatry work could be
grounded in discoverable, scientific principles about brain–
The direct link between biological processes in the brain
and a person’s behavior is widely
accepted today, but it seemed
radical three decades ago. When
Krystal was an undergraduate,
the late Yale psychiatry professor Daniel X. Freedman, MD,
directed him toward the lab of
Richard J. Miller, PhD, a pioneer in opiate-receptor research.
Since then, Krystal has built a
career bridging basic science

{ To nominate a subject for Q&A, contact

ditionally viewed mental
can be treated if there are
resources available, a sort
of add-on to health care.
Many people, includ-

behavior relationships.”

ing myself, believe that

with clinical understandings of
depression, alcoholism, posttraumatic stress disorder (PTSD),
and schizophrenia.
In this Yale Medicine
Magazine interview, Krystal discussed a deep and wide range of
topics from across his roles, which
also include chief of psychiatry at
Yale New Haven Hospital, editor
of the journal Biological
Psychiatry, director of clinical
neuroscience at the Department
of Veterans Affairs National
Center for PTSD, and numerous
advisory responsibilities.

Yale Medicine Magazine, 1 Church Street, Suite 300, New Haven, CT 06510, or email ymm@yale.edu.
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Statistics generally
show an upward trend
in rates of depression,
anxiety, and addiction. Are we dealing
with an actual increase
or just talking about
mental health more
openly? There is a lot

we need a new model
whereby mental health
is a core element of primary medical care. In
our society, more than
two-thirds of people are
routinely screened for
various forms of cancer—
but more than two-thirds
of people are not screened
for mental illness or
addiction. We need to
change that statistic.

Q&A WITH

John
Krystal

CONDUCTED BY

definitive treatment as

Kathleen Raven

soon as the problem is
diagnosed. We need to
offer more care like that.
If we diagnose depression,

Neuroscience research
is progressing rapidly.
Why might the public still
think of mental illness as
shrouded in mystery?

we need to make sure you
of services. Also, when

What is a dream you
have for the future of
psychiatry? We are work-

people fail to respond to

ing toward an era of preci-

established cancer treat-

sion psychiatry. By that

The symptoms of mental ill-

ments, a high percentage

I mean having tests that

ness—including changes in

of patients will enroll in

diagnose risk or disease

mood, patterns of thought,

a research study to test

processes for individu-

or behavior—can be con-

new treatments. That

als and that enable us to
engage specific prevention

get a comprehensive array

fusing or even frightening.

is not the way we deal

Providing a scientific foun-

with mental illness or

and treatment interven-

dation for understanding

addiction, where only a

tions. We envy cardiology,

these symptoms that guides

small fraction of patients

where one can diagnose

the processes of diagnosis

participate in research.

and treat hypertension

Which mental health
trend disturbs you most
today, and which trend
gives you the most
energy? The trends that

cardial infarction. We may

we also may need to deal

disturb me most also

with the societal issues

energize me the most: the

that increase risk, such

and treatment could have
profound implications for
how society thinks about
these problems.

R O B E R T L I S A K P H OTO S

What changes do we
need in how mental illness is treated? I think

and thereby prevent myobe able to use genetics
to identify people at risk
for problems, but then

we need a new model. As

increase in opiate-related

as childhood exposure to

a society and as a medi-

deaths and the increase

violence, abuse, neglect,

cal specialty, we need to

in suicide. Psychiatry is

and maternal depression

take responsibility for

unique in that mortality

and addiction. Future

the outcomes of mental-

from psychiatric illness

treatments may involve

illness treatment. To do

is increasing, whereas

gene- or cell-based thera-

that, we have to measure

mortality from practically

pies or procedures only

the outcomes of treatment

every other diagnosis is

imaginable on shows like

and use this information

decreasing. Cancer mor-

Star Trek, where a scan

to inform clinical prac-

tality, diabetes mortal-

is performed that tells us

tice. The current model

ity, and heart-disease

how to stimulate the brain

has some parallels to the

mortality are going down.

to alleviate symptoms.

way we treat infection, in

But suicide and addiction-

Who knows what will

that the most commonly

related deaths are going up.

come? Cure is not a word

used treatments are not

We have to do things dif-

that we use in psychiatry,

always the most effective.

ferently—and not just as a

but that too is simply a

We save the most effective

department or health care

reflection of the limits of

treatments for “treatment-

system but as a country.

our knowledge in compa-

resistant” symptoms. But

rison to the enormity of

that is not what we do in

the challenge of under-

cancer. There, we initiate

standing the brain.
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book review

		 A stimulating
book on hormones
By Cathy Shufro
In 1902, two English physi-

Everything. While tracing

from iatrogenic Creutzfeldt-

hypothyroidism; they rou-

ologists, William Bayliss and

the history of endocrinology,

Jakob Disease (iCJD) which

tinely prick the heels of new-

Ernest Starling, undertook

Epstein includes accounts of

is transmitted by prion-con-

borns to spot the deficiency.

gruesome experiments on a

hucksters, eugenicists, and

taminated growth hormone.

dog to prove that hormones

murderers. She writes about

Physicians now use synthetic

are essential to canine diges-

how hormones affect those

growth hormone.

tion. As Randi Hutter Epstein,

going through menopause,

One of Epstein’s favorite

to breach. She ignored a
rule at the Bronx Veterans

MD ’90, MPH, recounts in her

are intersex, are gender

stories is that of Rosalyn

Administration Hospital

new book, those experiments

transitioning, or experienc-

Sussman Yalow. Born in 1921

requiring pregnant women

confirmed that the glands

ing fluctuations in weight.

to Jewish immigrants, she

to resign in the fifth month.

found a spot in physics grad-

Journals repeatedly rejected
her first groundbreaking

scattered in the body—whether

Epstein hopes these tales

canine or human—have

will attract a broad audi-

uate school only after male

something in common: they

ence. “I’m trying to hook

students left for the mili-

article. In an interview,

produce hormones. The field of

in the reader who would

tary. “They had to go to war

Epstein described Yalow’s

endocrinology was born.

say, ‘I never thought I’d read

so I could get a PhD,” Yalow

advice to a group of third-

a book about the history of

declared. In 1959, she and

graders: “ ‘Hold onto all your

medicine—and I don’t know a

colleague Solomon Berson

rejection letters, because

The next year, animal
rights activists watched
Bayliss and Starling cut into

thing about chemistry—but I

developed a way to measure

you can display them dur-

a dog’s throat at a demo for

really understand it, because

hormones in the body. The

ing your Nobel awards cer-

medical students. Epstein tells

the stories are so great.’ ”

radioimmunoassay (RIA)

emony.’ Which Yalow did.”

how anti-vivisectionists pro-

One such story: In

detects hormones down to

She received the Nobel Prize

tested the dog’s treatment and

1960, when a doctor pre-

one-billionth of a gram per

in physiology or medicine in

erected a statue of a canine in

dicted that 7-year-old Jeff

milliliter of blood. As Epstein

1977 for inaugurating “a new

South London that read, “In

Balaban “might never make

writes, “That’s like being able

era of endocrinology.”

Memory of the Brown Terrier

it past four feet,” his mother

to measure the extra water in

Dog Done to Death.” Medical

took action: she recruited

a swimming pool after one

five years of researching and

students, in turn, mobbed the

pathologists to donate 156

swimmer sheds a tear.” RIA

writing the book, she saw a

streets, shouting, “Down with

human pituitary glands from

can detect various biological

pattern in how people have

the Brown Dog!”

cadavers each year to sup-

substances and is fundamen-

responded to discoveries

ply growth hormone for Jeff.

tal to fertility treatments and

about hormones. “Here are

This interweaving of

Epstein said that during

science and story is char-

As Epstein writes, “It would

detecting HIV. Pediatricians

these chemicals that seem to

acteristic of Aroused: The

take a graveyard of bodies

have used RIA to virtu-

control us, and we ask, ‘How

History of Hormones and

to make him grow.” Balaban

ally eliminate the thyroid

can we control them?’ That’s

How They Control Just about

proved lucky; since 1985,

deficit that causes congenital

human nature. We learn

{ Send notices of new books to

more than 226 other people

something about health or

treated with glands obtained

wellness or disease, and then

from cadavers have died

we want to take control.”

Yale Medicine Magazine, 1 Church Street, Suite 300, New Haven, CT 06510, or email ymm@yale.edu.
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Epstein describes the
barriers that Yalow had
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end note

Going once,
going twice
T H E AU C T I O N I N C A F É M E D

on the evening of December 6, 2018, was the 26th in an annual series

that has raised money for New Haven organizations that provide services to those in need. This
year’s auction raised $15,306 for four of the 28 organizations that applied for funding: Cornell ScottHill Health Center; Integrated Refugee and Immigrant Services (IRIS); Love Fed New Haven, which
makes healthy and affordable food available through community gardens; and Youth Continuum,
which serves homeless youth in the city.
Noting the auction’s long-standing tradition, organizer and second-year student Melanie Zheng
said, “It’s a great event because it allows us to help the community we were meant to serve.”
The auction began at 5 p.m. with music from the Railboys, a jazz ensemble made up of medical
students. At 6 p.m., William Stewart, PhD, who has taught anatomy to generations of Yale medical
students, took to the lectern as the first of several auctioneers. He would, he said, dispense with the
kindness and understanding he displays in the anatomy lab. “My one job is to get into your wallets,
so I am not going to show any mercy at all.”
As in past years, Stewart offered one of his signature bow ties, provoking the traditional rivalry
between students in the Physician Associate Program and medical students. The PA students won
with a bid of $2,080.
—John Curtis
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